Title,Authors,Platform,Cited_url,Cited_count,Year
2012 revised international chapel hill consensus conference nomenclature of vasculitides,"JC Jennette, RJ Falk, PA Bacon, N Basu, MC Cid, F Ferrario, ...","Arthritis & Rheumatism 65 (1), 1-11",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16745766602636736597,3407,2013
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies,"D Jayne, N Rasmussen, K Andrassy, P Bacon, JWC Tervaert, ...","New England Journal of Medicine 349 (1), 36-44",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11826968288782916456,1373,2003
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis,"RB Jones, JW Cohen Tervaert, T Hauser, R Luqmani, MD Morgan, ...","New England Journal of Medicine 363 (3), 211-220",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14826747387108983087,1264,2010
EULAR recommendations for the management of primary small and medium vessel vasculitis,"C Mukhtyar, L Guillevin, MC Cid, B Dasgupta, K de Groot, W Gross, ...","Annals of the rheumatic diseases 68 (3), 310-317",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11956144147875548870,986,2009
Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis,"DRW Jayne, G Gaskin, N Rasmussen, D Abramowicz, F Ferrario, ...","Journal of the American Society of Nephrology 18 (7), 2180-2188",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13271778683717562762,958,2007
Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis,"GB Appel, G Contreras, MA Dooley, EM Ginzler, D Isenberg, D Jayne, ...","Journal of the American Society of Nephrology 20 (5), 1103-1112",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12525874463988314251,895,2009
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of …,"GK Bertsias, M Tektonidou, Z Amoura, M Aringer, I Bajema, JHM Berden, ...","Annals of the rheumatic diseases 71 (11), 1771-1782",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17397035078714783438,783,2012
Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody–associated vasculitis,"K De Groot, N Rasmussen, PA Bacon, JWC Tervaert, C Feighery, ...",Arthritis & Rheumatism: Official Journal of the American College of …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15153745704848095574,762,2005
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody—associated vasculitis: a randomized trial,"K de Groot, L Harper, DRW Jayne, LFF Suarez, G Gregorini, WL Gross, ...","Annals of internal medicine 150 (10), 670-680",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5379586900917543975,675,2009
Genetically distinct subsets within ANCA-associated vasculitis,"PA Lyons, TF Rayner, S Trivedi, JU Holle, RA Watts, DRW Jayne, ...","New England Journal of Medicine 367 (3), 214-223",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1749639805644513196,655,2012
Antineutrophil cytoplasmic antibodies and the Churg–Strauss syndrome,"R Sablé-Fourtassou, P Cohen, A Mahr, C Pagnoux, L Mouthon, D Jayne, ...","Annals of internal medicine 143 (9), 632-638",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10508124188176530563,642,2005
EULAR recommendations for the management of large vessel vasculitis,"C Mukhtyar, L Guillevin, MC Cid, B Dasgupta, K de Groot, W Gross, ...","Annals of the rheumatic diseases 68 (3), 318-323",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7730031824761717398,633,2009
International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA),"J Savige, D Gillis, E Benson, D Davies, V Esnault, RJ Falk, E Chris Hagen, ...","American Journal of Clinical Pathology 111 (4), 507-513",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3854062553420661472,611,1999
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases,"S Van Assen, N Agmon-Levin, O Elkayam, R Cervera, MF Doran, ...","Annals of the rheumatic diseases 70 (3), 414-422",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13307777947392061321,546,2011
EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis,"B Hellmich, O Flossmann, WL Gross, P Bacon, JW Cohen-Tervaert, ...","Annals of the rheumatic diseases 66 (5), 605-617",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17826793659365652624,504,2007
Long-term patient survival in ANCA-associated vasculitis,"O Flossmann, A Berden, K de Groot, C Hagen, L Harper, C Heijl, ...","Annals of the rheumatic diseases 70 (3), 488-494",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15309614367856049756,503,2011
Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study,"AD Booth, MK Almond, A Burns, P Ellis, G Gaskin, GH Neild, M Plaisance, ...","American Journal of Kidney Diseases 41 (4), 776-784",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17440007870357488217,492,2003
Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis,"MA Dooley, D Jayne, EM Ginzler, D Isenberg, NJ Olsen, D Wofsy, F Eitner, ...","New England Journal of Medicine 365 (20), 1886-1895",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17525218614898558582,488,2011
Histopathologic classification of ANCA-associated glomerulonephritis,"AE Berden, F Ferrario, EC Hagen, DR Jayne, JC Jennette, K Joh, ...","Journal of the American Society of Nephrology 21 (10), 1628-1636",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10322627390583024569,477,2010
Modification and validation of the Birmingham Vasculitis Activity Score (version 3),"C Mukhtyar, R Lee, D Brown, D Carruthers, B Dasgupta, S Dubey, ...","Annals of the rheumatic diseases 68 (12), 1827-1832",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8729073565721103444,474,2009
Intravenous immunoglobulin for ANCA‐associated systemic vasculitis with persistent disease activity,"DRW Jayne, H Chapel, D Adu, S Misbah, D O'donoghue, D Scott, ...","Qjm 93 (7), 433-439",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11003886666652411503,467,2000
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis,"M Yates, RA Watts, IM Bajema, MC Cid, B Crestani, T Hauser, B Hellmich, ...","Annals of the rheumatic diseases 75 (9), 1583-1594",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6244552412934257368,434,2016
"Long‐term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re‐treatment","KGC Smith, RB Jones, SM Burns, DRW Jayne","Arthritis & Rheumatism 54 (9), 2970-2982",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17533196249700861156,433,2006
Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis,"RJ Falk, WL Gross, L Guillevin, GS Hoffman, DRW Jayne, JC Jennette, ...","Arthritis & Rheumatism 63 (4), 863-864",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3496293074095921390,425,2011
Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody–associated vasculitis: A randomized controlled trial,"TF Hiemstra, M Walsh, A Mahr, CO Savage, K De Groot, L Harper, ...","Jama 304 (21), 2381-2388",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14529898123865261589,424,2010
Prospective study of TNFα blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis,"A Booth, L Harper, T Hammad, P Bacon, M Griffith, J Levy, C Savage, ...","Journal of the American Society of Nephrology 15 (3), 717-721",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10981406451548890540,424,2004
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force,"RF Van Vollenhoven, M Mosca, G Bertsias, D Isenberg, A Kuhn, ...","Annals of the rheumatic diseases 73 (6), 958-967",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9354426477424855370,367,2014
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies,"M Mosca, C Tani, M Aringer, S Bombardieri, D Boumpas, R Brey, ...","Annals of the rheumatic diseases 69 (7), 1269-1274",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18031686997004760594,352,2010
A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody–associated vasculitis,"RB Jones, AJ Ferraro, AN Chaudhry, P Brogan, AD Salama, KGC Smith, ...",Arthritis & Rheumatism: Official Journal of the American College of …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2020850231807985725,351,2009
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force,"C Mukhtyar, O Flossmann, B Hellmich, P Bacon, M Cid, ...","Annals of the rheumatic diseases 67 (7), 1004-1010",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4273050243227819206,348,2008
Treatment of systemic vasculitis with pooled intravenous immunoglobulin,"DRW Jayne, CM Lockwood, MJ Davies, CJV Fox, CM Black","The Lancet 337 (8750), 1137-1139",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8247209312045434427,332,1991
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up,"L Harper, MD Morgan, M Walsh, P Hoglund, K Westman, O Flossmann, ...","Annals of the rheumatic diseases 71 (6), 955-960",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15226726517645661022,328,2012
Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis,"DRW Jayne, PD Marshall, SJ Jones, CM Lockwood","Kidney international 37 (3), 965-970",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6855819620559598491,300,1990
Autologous stem cell transplantation for systemic lupus erythematosus,"D Jayne, A Tyndall","Lupus 13 (5), 359-365",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4051260495224674960,297,2004
Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis,"MA Little, P Nightingale, CA Verburgh, T Hauser, K De Groot, C Savage, ...","Annals of the rheumatic diseases 69 (6), 1036-1043",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17819500937787848035,289,2010
A CD8,"EF McKinney, PA Lyons, EJ Carr, JL Hollis, DRW Jayne, LC Willcocks, ...","Nature medicine 16 (5), 586",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8122020923611499425,274,2010
Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups,"HA Hauer, IM Bajema, HC Van Houwelingen, F Ferrario, LH Noël, ...","Kidney international 61 (1), 80-89",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2770759822148445192,273,2002
"T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection","EF McKinney, JC Lee, DRW Jayne, PA Lyons, KGC Smith","Nature 523 (7562), 612",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4919430464560056540,260,2015
Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation,"AD Booth, S Wallace, CM McEniery, J Brown, DRW Jayne, IB Wilkinson",Arthritis & Rheumatism: Official Journal of the American College of …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=609278132704625126,260,2004
Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study,"D Isenberg, GB Appel, G Contreras, MA Dooley, EM Ginzler, D Jayne, ...","Rheumatology 49 (1), 128-140",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6570260766673806540,246,2009
ANCA and predicting relapse in systemic vasculitis,"DRW Jayne, G Gaskin, CD Pusey, CM Lockwood","QJM: An International Journal of Medicine 88 (2), 127-133",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12909201085065346823,246,1995
Risk factors for relapse of antineutrophil cytoplasmic antibody–associated vasculitis,"M Walsh, O Flossmann, A Berden, K Westman, P Höglund, C Stegeman, ...","Arthritis & Rheumatism 64 (2), 542-548",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=710898075538576351,243,2012
Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the UK,"S Fujimoto, RA Watts, S Kobayashi, K Suzuki, DRW Jayne, DGI Scott, ...","Rheumatology 50 (10), 1916-1920",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16397016876922562488,235,2011
Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody–associated vasculitis,"RM Smith, RB Jones, MJ Guerry, S Laurino, F Catapano, A Chaudhry, ...","Arthritis & Rheumatism 64 (11), 3760-3769",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13913793992991572965,233,2012
Tumor necrosis factor α blockade with infliximab for refractory uveitis and scleritis,"CC Murphy, WH Ayliffe, A Booth, D Makanjuola, PA Andrews, D Jayne","Ophthalmology 111 (2), 352-356",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8783570399602682245,225,2004
Churg‐Strauss syndrome with poor‐prognosis factors: a prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty‐eight patients,"P Cohen, C Pagnoux, A Mahr, JP Arène, L Mouthon, V Le Guern, ...","Arthritis Care & Research 57 (4), 686-693",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12989759320948078475,224,2007
Eosinophilic granulomatosis with polyangiitis (Churg–Strauss)(EGPA) Consensus Task Force recommendations for evaluation and management,"M Groh, C Pagnoux, C Baldini, E Bel, P Bottero, V Cottin, K Dalhoff, ...","European journal of internal medicine 26 (7), 545-553",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1722079896360383255,214,2015
BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis,"C Lapraik, R Watts, P Bacon, D Carruthers, K Chakravarty, D D’Cruz, ...","Rheumatology 46 (10), 1615-1616",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10201426058230207679,212,2007
Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis,"ME Wechsler, P Akuthota, D Jayne, P Khoury, A Klion, CA Langford, ...","New England Journal of Medicine 376 (20), 1921-1932",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2976415240684946238,209,2017
Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation,"AD Booth, DRW Jayne, RK Kharbanda, CM McEniery, IS Mackenzie, ...","Circulation 109 (14), 1718-1723",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17496171070690109066,209,2004
Update on the European vasculitis study group trials,"D Jayne, European Vasculitis Study Group","Current opinion in rheumatology 13 (1), 48-55",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4945542466303281585,208,2001
Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts,"C Díaz-Lagares, S Croca, S Sangle, EM Vital, F Catapano, ...","Autoimmunity reviews 11 (5), 357-364",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1315816745456974330,205,2012
"Pulmonary renal syndrome: a 4-year, single-center experience","H Gallagher, JTC Kwan, DRW Jayne","American Journal of Kidney Diseases 39 (1), 42-47",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7966113909080789192,204,2002
Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group,"DRW Jayne, N Rasmussen","Mayo Clinic Proceedings 72 (8), 737-747",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17175591607442590039,203,1997
BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis,"E Ntatsaki, D Carruthers, K Chakravarty, D D’Cruz, L Harper, D Jayne, ...","Rheumatology 53 (12), 2306-2309",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12301196765815348264,197,2014
"A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis","H Trachtman, FC Fervenza, DS Gipson, P Heering, DRW Jayne, H Peters, ...","Kidney international 79 (11), 1236-1243",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8645570640986873348,197,2011
Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody–associated vasculitis: A meta‐analysis,"M Walsh, PA Merkel, A Mahr, D Jayne","Arthritis care & research 62 (8), 1166-1173",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15458642395425004674,187,2010
Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis,"M Walsh, M James, D Jayne, M Tonelli, BJ Manns, BR Hemmelgarn","Clinical Journal of the American Society of Nephrology 2 (5), 968-975",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10849426013131677074,187,2007
Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients,"HA Hauer, IM Bajema, HC Van Houwelingen, F Ferrario, LH Noël, ...","Kidney international 62 (5), 1732-1742",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14054333661953942654,187,2002
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial,"M Walsh, PA Merkel, CA Peh, W Szpirt, L Guillevin, CD Pusey, J DeZoysa, ...","Trials 14 (1), 73",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1425196900451335236,183,2013
EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis,"N Basu, R Watts, I Bajema, B Baslund, T Bley, M Boers, P Brogan, ...","Annals of the rheumatic diseases 69 (10), 1744-1750",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3684123698415020210,182,2010
"Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double‐blind, phase III study","EF Mysler, AJ Spindler, R Guzman, M Bijl, D Jayne, RA Furie, ...","Arthritis & Rheumatism 65 (9), 2368-2379",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8540838791585394737,180,2013
Anti‐idiotypes against anti‐neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with …,"F Rossi, DRW Jayne, CM Lockwood, MD Kazatchkine","Clinical & Experimental Immunology 83 (2), 298-303",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2704556028350847570,174,1991
The impact of ,"M Fuchs, M Briel, T Daikeler, UA Walker, H Rasch, S Berg, QKT Ng, ...","European journal of nuclear medicine and molecular imaging 39 (2), 344-353",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7060939130518612557,167,2012
Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis,"MJCJ Guerry, P Brogan, IN Bruce, DP D'Cruz, L Harper, R Luqmani, ...","Rheumatology 51 (4), 634-643",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16540547276568400158,162,2011
Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis,"DRW Jayne, AN Bruchfeld, L Harper, M Schaier, MC Venning, P Hamilton, ...","Journal of the American Society of Nephrology 28 (9), 2756-2767",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5461250082337578757,160,2017
Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear,"M Walsh, A Casian, O Flossmann, K Westman, P Höglund, C Pusey, ...","Kidney international 84 (2), 397-402",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17397918070598148211,159,2013
2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative,"C Dejaco, YP Singh, P Perel, A Hutchings, D Camellino, S Mackie, A Abril, ...","Arthritis & Rheumatology 67 (10), 2569-2580",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4132200690858523279,156,2015
Long-term follow-up of relapsing/refractory anti-neutrophil cytoplasm antibody associated vasculitis treated with the lymphocyte depleting antibody alemtuzumab (CAMPATH-1H),"M Walsh, A Chaudhry, D Jayne","Annals of the rheumatic diseases 67 (9), 1322-1327",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16811245160220298486,156,2008
Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis,"M Walsh, F Catapano, W Szpirt, K Thorlund, A Bruchfeld, L Guillevin, ...","American Journal of Kidney Diseases 57 (4), 566-574",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10461633470022371788,153,2011
Membranoproliferative glomerulonephritis,"B Alchi, D Jayne","Pediatric Nephrology 25 (8), 1409-1418",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14864428155095332587,153,2010
Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis,"A Mahr, S Katsahian, H Varet, L Guillevin, EC Hagen, P Höglund, ...","Annals of the rheumatic diseases 72 (6), 1003-1010",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12319781726655777156,152,2013
ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin,"DRW Jayne, VLM Esnault, CM Lockwood","Journal of autoimmunity 6 (2), 207-219",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10192273059035150415,145,1993
Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement,"RAFL van Wijngaarden, HA Hauer, R Wolterbeek, DRW Jayne, G Gaskin, ...","Journal of the American Society of Nephrology 17 (8), 2264-2274",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5180069890106742205,144,2006
European consensus statement on the terminology used in the management of lupus glomerulonephritis,"C Gordon, D Jayne, C Pusey, D Adu, Z Amoura, M Aringer, J Ballerin, ...","Lupus 18 (3), 257-263",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16596904763538378375,143,2009
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial,"RB Jones, S Furuta, JWC Tervaert, T Hauser, R Luqmani, MD Morgan, ...","Annals of the rheumatic diseases 74 (6), 1178-1182",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=568052535060834856,142,2015
Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials,"J Robson, H Doll, R Suppiah, O Flossmann, L Harper, P Höglund, ...","Annals of the rheumatic diseases 74 (1), 177-184",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2617972973589397264,138,2015
Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis,"MH Zhao, DRW Jayne, LG Ardiles, F Culley, ME Hodson, CM Lockwood","QJM: An International Journal of Medicine 89 (4), 259-266",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9654940695979436737,137,1996
Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based …,"S Van Assen, O Elkayam, N Agmon-Levin, R Cervera, MF Doran, ...","Autoimmunity reviews 10 (6), 341-352",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5273914429380237356,133,2011
Rituximab is effective in the treatment of refractory Churg–Strauss syndrome and is associated with diminished T-cell interleukin-5 production,"RJ Pepper, MA Fabre, C Pavesio, G Gaskin, RB Jones, D Jayne, ...","Rheumatology 47 (7), 1104-1105",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5900671701499368417,133,2008
Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA) A report on the second phase of an international …,"EC Hagen, K Andrassy, E Csernok, MR Daha, G Gaskin, WL Gross, ...","Journal of immunological Methods 196 (1), 1-15",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18155673767550455285,133,1996
Development of comprehensive disease assessment in systemic vasculitis,"O Flossmann, P Bacon, K De Groot, D Jayne, N Rasmussen, P Seo, ...","Postgraduate medical journal 84 (989), 143-152",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1185431902961707801,132,2008
A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis,"R Suppiah, A Judge, R Batra, O Flossmann, L Harper, P Höglund, ...","Arthritis care & research 63 (4), 588-596",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10834194239655415519,131,2011
Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis,"M Koukoulaki, DRW Jayne","Nephron Clinical Practice 102 (3-4), c100-c107",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14313170178452913985,128,2006
Intravenous immunoglobulin as sole therapy for systemic vasculitis,"DRW Jayne, CM Lockwood","Rheumatology 35 (11), 1150-1153",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17217685240382548402,128,1995
"Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease","DM Roberts, RB Jones, RM Smith, F Alberici, DS Kumaratne, S Burns, ...","Journal of autoimmunity 57, 60-65",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11952325646856825211,127,2015
Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis,"G Frampton, DRW Jayne, GJ Perry, CM Lockwood, JS Cameron","Clinical & Experimental Immunology 82 (2), 227-232",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18431601032029689780,124,1990
Increased apoptosis of bone marrow CD34,"HA Papadaki, DT Boumpas, FM Gibson, DR Jayne, JS Axford, ...","British journal of haematology 115 (1), 167-174",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2692404567556419225,122,2001
Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial,"A Howman, TL Chapman, MM Langdon, C Ferguson, D Adu, J Feehally, ...","The Lancet 381 (9868), 744-751",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1904672566475573255,121,2013
Rituximab in Churg-Strauss syndrome,"M Koukoulaki, KGC Smith, DRW Jayne","Annals of the Rheumatic Diseases 65 (4), 557-559",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3992656435486133714,121,2006
Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg–Strauss),"AJ Mohammad, A Hot, F Arndt, F Moosig, MJ Guerry, N Amudala, R Smith, ...","Annals of the rheumatic diseases 75 (2), 396-401",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17317706266506976437,119,2016
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS),"R Van Vollenhoven, A Voskuyl, G Bertsias, C Aranow, M Aringer, ...","Annals of the rheumatic diseases 76 (3), 554-561",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1806021568569253992,115,2017
Anti-neutrophil cytoplasmic antibodies stimulate release of neutrophil microparticles,"Y Hong, D Eleftheriou, AAK Hussain, FE Price-Kuehne, CO Savage, ...","Journal of the American Society of Nephrology 23 (1), 49-62",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=176558357609865364,115,2012
EUVAS (European Vasculitis Study Group). Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a …,"K De Groot, L Harper, DR Jayne, LF Flores Suarez, G Gregorini, ...","Ann Intern Med 150 (10), 670-80",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4210945085376431568,115,2009
Safety and efficacy of TNFα blockade in relapsing vasculitis,"AD Booth, HJ Jefferson, W Ayliffe, PA Andrews, DR Jayne","Annals of the rheumatic diseases 61 (6), 559-559","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3561353353694207220,15674173136818046448",114,2002
B‐cell depletion with rituximab for refractory head and neck Wegener’s granulomatosis: a cohort study,"M Martinez Del Pero, A Chaudhry, RB Jones, P Sivasothy, P Jani, ...","Clinical Otolaryngology 34 (4), 328-335",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6994315455988488063,109,2009
Remission induction in Behcet’s disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H,"CM Lockwood, G Hale, H Waldman, DRW Jayne","Rheumatology 42 (12), 1539-1544",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7250911711957940382,109,2003
"European therapeutic trials in ANCA‐associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials EUROPEAN COMMUNITY STUDY GROUP ON CLINICAL …","N Rasmussen, DRW Jayne, D Abramowicz, K Andrassy, PA Bacon, ...","Clinical & Experimental Immunology 101, 29-34",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1028924129593301754,108,1995
Clinical significance of anti-endothelial cell antibodies in systemic vasculitis: a longitudinal study comparing anti-endothelial cell antibodies and anti-neutrophil cytoplasm …,"TM Chan, G Frampton, DRW Jayne, GJ Perry, CM Lockwood, ...","American journal of kidney diseases 22 (3), 387-392",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10320663608331124601,107,1993
Brief Report: Long‐term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic …,"M Faurschou, K Westman, N Rasmussen, K de Groot, O Flossmann, ...","Arthritis & Rheumatism 64 (10), 3472-3477",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12681079350120916386,101,2012
Diagnosis and management of ANCA associated vasculitis,"A Berden, A Göçeroğlu, D Jayne, R Luqmani, N Rasmussen, JA Bruijn, ...","Bmj 344, e26",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10099315664029461337,101,2012
Deoxyspergualin in relapsing and refractory Wegener’s granulomatosis,"O Flossmann, B Baslund, A Bruchfeld, JWC Tervaert, C Hall, P Heinzel, ...","Annals of the rheumatic diseases 68 (7), 1125-1130",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=971274667418876523,97,2009
"Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS)","A Sinclair, G Appel, MA Dooley, E Ginzler, D Isenberg, D Jayne, D Wofsy, ...","Lupus 16 (12), 972-980",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8094356346254457679,97,2007
Evidence‐based treatment of systemic vasculitis,D Jayne,"Rheumatology 39 (6), 585-595",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12406506543405222639,97,2000
Renal vasculitis in Japan and the UK—are there differences in epidemiology and clinical phenotype?,"RA Watts, DGI Scott, DRW Jayne, T Ito-Ihara, E Muso, S Fujimoto, ...","Nephrology Dialysis Transplantation 23 (12), 3928-3931",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1514600549711651976,96,2008
Antineutrophil cytoplasm antibodies in Kawasaki disease.,"CO Savage, J Tizard, DRW Jayne, CM Lockwood, MJ Dillon","Archives of disease in childhood 64 (3), 360-363",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10840413009562079811,96,1989
Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis,"X Bossuyt, JWC Tervaert, Y Arimura, D Blockmans, LF Flores-Suárez, ...","Nature Reviews Rheumatology 13 (11), 683-692",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4159752296904215657,94,2017
B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumaband implications for study design,"V Reddy, D Jayne, D Close, D Isenberg","Arthritis research & therapy 15 (1), S2",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3100271153272783983,92,2013
Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus,"F Catapano, AN Chaudhry, RB Jones, KGC Smith, DW Jayne","Nephrology Dialysis Transplantation 25 (11), 3586-3592",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17048968432104198200,91,2010
Pooled intravenous immunoglobulin in the management of systemic vasculitis,"DRW Jayne, CM Lockwood","ANCA-associated vasculitides, 469-472",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7389782503344119789,90,1993
Treatment of systemic lupus erythematosus with mycophenolate mofetil,"D Adu, J Cross, DRW Jayne","Lupus 10 (3), 203-208",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13059021147318652881,89,2001
European Vasculitis Study Group (EUVAS). Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a …,"TF Hiemstra, M Walsh, A Mahr, CO Savage, K De Groot, L Harper, ...","Jama 304 (21), 2381-8",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13389828089039518658,88,2010
The diagnosis of vasculitis,D Jayne,"Best Practice & Research Clinical Rheumatology 23 (3), 445-453",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7178218536455032320,87,2009
Anti–glomerular basement membrane disease after alemtuzumab,"MR Clatworthy, EF Wallin, DR Jayne","New England Journal of Medicine 359 (7), 768-769",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3561566113777140721,86,2008
European Vasculitis Study Group: A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies,"D Jayne, N Rasmussen, K Andrassy, P Bacon, JW Tervaert, J Dadoniené, ...","N Engl J Med 349 (1), 36-44",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13797761022174070802,86,2003
Prospective study of TNFα blockade with adalimumab in ANCA-associated systemic vasculitis with renal involvement,"S Laurino, A Chaudhry, A Booth, G Conte, D Jayne","Nephrology Dialysis Transplantation 25 (10), 3307-3314",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1372249420721932539,85,2010
Severe pulmonary hemorrhage and systemic vasculitis in association with circulating anti-neutrophil cytoplasm antibodies of IgM class only.,"DR Jayne, SJ Jones, A Severn, S Shaunak, J Murphy, CM Lockwood","Clinical nephrology 32 (3), 101-106",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12024923362574369461,85,1989
"Rituximab in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis and systemic lupus erythematosus: past, present and future","M Walsh, D Jayne","Kidney international 72 (6), 676-682",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1270875563640478263,84,2007
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults,"C Gordon, MB Amissah-Arthur, M Gayed, S Brown, IN Bruce, D D’Cruz, ...","Rheumatology 57 (1), e1-e45",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12680974691847506826,81,2017
Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials,"R Suppiah, RDM Hadden, R Batra, NK Arden, MP Collins, L Guillevin, ...","Rheumatology 50 (12), 2214-2222",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14461243592126886171,81,2011
Tubular lesions predict renal outcome in antineutrophil cytoplasmic antibody–associated glomerulonephritis after rituximab therapy,"AE Berden, RB Jones, DD Erasmus, M Walsh, LH Noël, F Ferrario, ...","Journal of the American Society of Nephrology 23 (2), 313-321",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11812676020693797767,77,2012
"Plasma exchange in the treatment of Wegener's granulomatosis, microscopic polyangiitis, Churg–Strauss syndrome and renal limited vasculitis","A Casian, D Jayne","Current opinion in rheumatology 23 (1), 12-17",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12617805550773939423,75,2011
Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis,"PA Lyons, EF McKinney, TF Rayner, A Hatton, HB Woffendin, ...","Annals of the rheumatic diseases 69 (6), 1208-1213",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10299027637984684041,75,2010
Non-transplant uses of mycophenolate mofetil,D Jayne,"Current opinion in nephrology and hypertension 8 (5), 563-567",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7192218607081808825,75,1999
Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis,"RAFL van Wijngaarden, HA Hauer, R Wolterbeek, DRW Jayne, G Gaskin, ...","Journal of the American Society of Nephrology 18 (7), 2189-2197",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16763260601372759729,73,2007
Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): a study of 157 patients by the Groupe d'Etudes et de Recherche sur les …,"V Cottin, E Bel, P Bottero, K Dalhoff, M Humbert, R Lazor, RA Sinico, ...","Autoimmunity reviews 16 (1), 1-9",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7664189116818855622,72,2017
Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis,"F Alberici, RM Smith, RB Jones, DM Roberts, LC Willcocks, A Chaudhry, ...","Rheumatology 54 (7), 1153-1160",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12648758823201904176,72,2014
The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease,"H Marco, RM Smith, RB Jones, MJ Guerry, F Catapano, S Burns, ...","BMC musculoskeletal disorders 15 (1), 178",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12089261057887600428,72,2014
B-cell depletion in the treatment of lupus nephritis,"JW Gregersen, DRW Jayne","Nature Reviews Nephrology 8 (9), 505",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3410366547705617544,72,2012
A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis,"R Suppiah, C Mukhtyar, O Flossmann, F Alberici, B Baslund, R Batra, ...","Rheumatology 50 (5), 899-905",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5873281662874824014,71,2010
Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units,"CM Stirling, P Mathieson, JM Boulton-Jones, J Feehally, D Jayne, ...","Qjm 98 (6), 443-449",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5739445549208493307,71,2005
IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis.,"DR Jayne, AP Weetman, CM Lockwood","Clinical and experimental immunology 84 (3), 476",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11686457126634139906,71,1991
Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus,"GG Illei, R Cervera, RK Burt, A Doria, F Hiepe, D Jayne, S Pavletic, ...","Annals of the rheumatic diseases 70 (12), 2071-2074",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10499141487382526810,70,2011
European Vasculitis Study Group (EUVAS). Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against …,"C Mukhtyar, O Flossmann, B Hellmich, P Bacon, M Cid, ...","Ann Rheum Dis 67 (7), 1004-10",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16842664108942345696,70,2008
Human T-follicular helper and T-follicular regulatory cell maintenance is independent of germinal centers,"EF Wallin, EC Jolly, O Suchánek, JA Bradley, M Espéli, DRW Jayne, ...","Blood 124 (17), 2666-2674",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13829429636208202811,69,2014
ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis,"LF Quintana, NS Peréz, E De Sousa, LM Rodas, MH Griffiths, M Solé, ...","Nephrology Dialysis Transplantation 29 (9), 1764-1769",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7986849508255784717,69,2014
Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry,"B Alchi, D Jayne, M Labopin, O Kotova, V Sergeevicheva, T Alexander, ...","Lupus 22 (3), 245-253",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12960864657219457472,69,2013
Progress of treatment in ANCA‐associated vasculitis,D Jayne,"Nephrology 14 (1), 42-48",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10155544362185474738,68,2009
Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice,"M Mosca, C Tani, M Aringer, S Bombardieri, D Boumpas, R Cervera, ...","Autoimmunity reviews 10 (7), 383-388",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3081341054526045033,67,2011
American College of Rheumatology; American Society of Nephrology; European League Against Rheumatism. Granulomatosis with polyangiitis (Wegener’s): an alternative name for …,"RJ Falk, WL Gross, L Guillevin, GS Hoffman, DR Jayne, JC Jennette, ...","Arthritis Rheum 63 (4), 863-4",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14729243358433341553,67,2011
Mortality in Wegener’s granulomatosis: a bimodal pattern,"R Luqmani, R Suppiah, CJ Edwards, R Phillip, J Maskell, D Culliford, ...","Rheumatology 50 (4), 697-702",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16761396432981503969,67,2010
Lupus nephritis management guidelines compared,"S Wilhelmus, IM Bajema, GK Bertsias, DT Boumpas, C Gordon, ...","Nephrology Dialysis Transplantation 31 (6), 904-913",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2001784487776466633,66,2015
Efficacy and safety of enteric-coated mycophenolate sodium in combination with two glucocorticoid regimens for the treatment of active lupus nephritis,"M Zeher, A Doria, J Lan, G Aroca, D Jayne, I Boletis, F Hiepe, H Prestele, ...","Lupus 20 (14), 1484-1493",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8960969000939927087,66,2011
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus,"A Fanouriakis, M Kostopoulou, A Alunno, M Aringer, I Bajema, JN Boletis, ...","Annals of the rheumatic diseases 78 (6), 736-745","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5852475271500600191,12855571485763184017",65,2019
Progress in treatment of ANCA-associated vasculitis,"RM Smith, RB Jones, DRW Jayne","Arthritis research & therapy 14 (2), 210",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14421791708546641810,65,2012
European Vasculitis Study Group. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis,DR Jayne,"J Am Soc Nephrol 18, 2180-2188",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1876952527251176525,65,2007
European Vasculitis Study Group (EUVAS): Renal histology in ANCA-associated vasculitis: Differences between diagnostic and serologic subgroups,"HA Hauer, IM Bajema, HC Van Houwelingen, F Ferrario, LH Noël, ...","Kidney Int 61 (1), 80-9",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10840594395116626200,65,2002
"Cerebral vasculitis—recognition, diagnosis and management","NJ Scolding, DRW Jayne, JP Zajicek, PAR Meyer, EP Wraight, ...","QJM: An International Journal of Medicine 90 (1), 61-73",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=912926647024393452,65,1997
Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials,"J Robson, H Doll, R Suppiah, O Flossmann, L Harper, P Höglund, ...","Rheumatology 54 (3), 471-481",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6414183961611613784,64,2014
Antineutrophil cytoplasm antibody–associated vasculitis: recent developments,"S Furuta, DRW Jayne","Kidney international 84 (2), 244-249",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12428605888655756896,64,2013
Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis,"T Dörner, D Isenberg, D Jayne, H Wiendl, D Zillikens, G Burmester, ...","Autoimmunity reviews 9 (2), 82-89",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6330880126856848435,64,2009
Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis,"A Karras, C Pagnoux, M Haubitz, K de Groot, X Puechal, JWC Tervaert, ...","Annals of the rheumatic diseases 76 (10), 1662-1668",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8530200470564500703,63,2017
"Frequency, risk factors and prophylaxis of infection in ANCA‐associated vasculitis","A Kronbichler, DRW Jayne, G Mayer","European journal of clinical investigation 45 (3), 346-368",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3212705188663746888,63,2015
Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis,"PA Merkel, DD Cuthbertson, B Hellmich, GS Hoffman, DRW Jayne, ...","Annals of the rheumatic diseases 68 (1), 103-106",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9273488274790887414,59,2009
Health‐related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody–associated vasculitis,"M Walsh, C Mukhtyar, A Mahr, K Herlyn, R Luqmani, PA Merkel, ...","Arthritis care & research 63 (7), 1055-1061",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5401227359620201628,57,2011
Association of IgM with IgG ANCA in patients presenting with pulmonary hemorrhage,"VLM Esnault, B Soleimani, MT Keogan, AA Brownlee, DRW Jayne, ...","Kidney international 41 (5), 1304-1310",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6078098685678740289,57,1992
Adjunctive plasma exchange is superior to methylprednisolone in acute renal failure due to ANCA-associated glomerulonephritis.,"G Gaskin, DR Jayne","Journal of the American Society of Nephrology 13, 2A-3A",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6744034565005669230,55,2002
Molecular analysis of C3 allotypes in patients with systemic vasculitis,"JE Finn, L Zhang, S Agrawal, DRW Jayne, DBG Oliveira, PW Mathieson","Nephrology Dialysis Transplantation 9 (11), 1564-1567",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7033407711235508528,54,1994
The characterisation and determinants of quality of life in ANCA associated vasculitis,"N Basu, A McClean, L Harper, EN Amft, N Dhaun, RA Luqmani, MA Little, ...","Annals of the rheumatic diseases 73 (1), 207-211",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13540667388221904280,53,2014
"Challenges in the management of microscopic polyangiitis: past, present and future",D Jayne,"Current opinion in rheumatology 20 (1), 3-9",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=279603040816799013,53,2008
Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review,"A Kronbichler, B Brezina, LF Quintana, DRW Jayne","Autoimmunity reviews 15 (1), 38-49",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10396549378249121075,52,2016
Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort,"B Alchi, M Griffiths, M Sivalingam, D Jayne, K Farrington","Nephrology Dialysis Transplantation 30 (5), 814-821",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16070589498217994900,51,2015
Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study,"Z Hruskova, AL Casian, P Konopasek, B Svobodova, D Frausova, ...","Scandinavian journal of rheumatology 42 (3), 211-214",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5243007980877395211,51,2013
Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan,"S Furuta, AN Chaudhry, Y Hamano, S Fujimoto, H Nagafuchi, H Makino, ...","The Journal of rheumatology 41 (2), 325-333",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16193801322486622073,50,2014
The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritis,"L Arnaud, H Devilliers, SL Peng, A Mathian, N Costedoat-Chalumeau, ...","Autoimmunity reviews 12 (2), 204-209",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5947145432159898004,50,2012
Remission of refractory hepatitis C-negative cryoglobulinaemic vasculitis after rituximab and infliximab,"M Koukoulaki, SC Abeygunasekara, KGC Smith, DRW Jayne","Nephrology Dialysis Transplantation 20 (1), 213-216",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6123551629033228981,50,2005
A randomized trial of mycophenolate mofetil versus cyclophosphamide for remission induction of ANCA-associated vasculitis:“MYCYC”. On behalf of the European vasculitis study group,"R Jones, L Harper, J Ballarin, D Blockmans, P Brogan, A Bruchfeld, M Cid, ...","La Presse Médicale 42 (4P2), 678-679",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3044914350477505114,49,2013
Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7.,"PA Merkel, P Seo, P Aries, T Neogi, A Villa-Forte, M Boers, D Cuthbertson, ...","The Journal of Rheumatology 32 (12), 2488-2495",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15464978166945969544,49,2005
What nephrologists need to know about antiphospholipid syndrome,"B Alchi, M Griffiths, D Jayne","Nephrology Dialysis Transplantation 25 (10), 3147-3154",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11732996257548955550,48,2010
5 Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic antibodies,"JSF Sanders, MC Slot, CA Stegeman","Disease activity in ANCA-asscociated vasculitis 349 (21), 65","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17472196844703444182,10654865949227860030",48,2009
The future of damage assessment in vasculitis.,"P Seo, RA Luqmani, O Flossmann, B Hellmich, K Herlyn, GS Hoffman, ...","The Journal of Rheumatology 34 (6), 1357-1371",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15249098244314306312,48,2007
Mycophenolate mofetil for remission induction in severe lupus nephritis,"J Cross, A Dwomoa, P Andrews, A Burns, C Gordon, J Main, P Mathieson, ...","Nephron Clinical Practice 100 (3), c92-c100",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=671790687610691918,47,2005
Distribution of MHC class II alleles in primary systemic vasculitis,"L Zhang, DRW Jayne, MH Zhao, CM Lockwood, DBG Oliveira","Kidney international 47 (1), 294-298",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5341630142901384291,47,1995
Beyond immunosuppression–challenges in the clinical management of lupus nephritis,"S Masood, D Jayne, Y Karim","Lupus 18 (2), 106-115",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12629064227448163414,46,2009
The cost-effectiveness of mycophenolate mofetil as firstline therapy in active lupus nephritis,"ECF Wilson, DRW Jayne, E Dellow, RJ Fordham","Oxford University Press 46 (7), 1096-1101","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11483196804916535401,7043702503467200010",46,2007
Developing and refining new candidate criteria for systemic lupus erythematosus classification: an international collaboration,"SK Tedeschi, SR Johnson, D Boumpas, D Daikh, T Dörner, D Jayne, ...","Arthritis care & research 70 (4), 571-581",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14460717940143985761,44,2018
Association of ANCA isotype and affinity with disease expression,"VLM Esnault, N Ronda, DRW Jayne, CM Lockwood","Journal of autoimmunity 6 (2), 197-205",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9512235114767728556,44,1993
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis,"C Mukhtyar, B Hellmich, D Jayne, O Flossmann, R Luqmani","Clinical and experimental rheumatology 24 (6), S93",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8080225098002110813,43,2006
Influence of immunoadsorption on the removal of immunoglobulin G autoantibodies in crescentic glomerulonephritis,"VLM Esnault, A Testa, DRW Jayne, JP Soulillou, J Guenel","Nephron 65 (2), 180-184",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18376377415177211922,43,1993
Anti-neutrophil cytoplasm antibodies in patients with monoclonal gammopathies.,"VL Esnault, DR Jayne, MT Keogan, AA Brownlee, A Testa, D Lecarrer, ...","Journal of clinical & laboratory immunology 32 (4), 153-159",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13961282644970378910,43,1990
Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis,"EE van Daalen, R Rizzo, A Kronbichler, R Wolterbeek, JA Bruijn, ...","Annals of the Rheumatic Diseases 76 (6), 1064-1069",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4103029164715456492,42,2017
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis with poor kidney function: a subgroup analysis of the Aspreva Lupus Management Study,"M Walsh, N Solomons, L Lisk, DRW Jayne","American Journal of Kidney Diseases 61 (5), 710-715",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1087677693090456284,42,2013
Management of alveolar hemorrhage in lung vasculitides,"A Casian, D Jayne","Seminars in respiratory and critical care medicine 32 (03), 335-345",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9451142314517135907,42,2011
IgG subclass distribution and relative functional affinity of anti-myeloperoxidase antibodies in systemic vasculitis at presentation and during follow-up.,"VL Esnault, DR Jayne, AP Weetman, CM Lockwood","Immunology 74 (4), 714",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5311439256448019867,42,1991
Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: a case series,"DM Roberts, RB Jones, RM Smith, F Alberici, DS Kumaratne, S Burns, ...","Journal of autoimmunity 57, 24-29",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8577832003237211971,41,2015
Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index,"R Suppiah, O Flossman, C Mukhtyar, F Alberici, B Baslund, D Brown, ...","Annals of the rheumatic diseases 70 (1), 80-85",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1137764563001723321,41,2011
Complement in ANCA-associated vasculitis: mechanisms and implications for management,"M Chen, DRW Jayne, MH Zhao","Nature Reviews Nephrology 13 (6), 359-367",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6476895628348863824,40,2017
Long‐term followup of a multicenter cohort of 101 patients with eosinophilic granulomatosis with polyangiitis (Churg‐Strauss),"CA Durel, J Berthiller, S Caboni, D Jayne, J Ninet, A Hot","Arthritis care & research 68 (3), 374-387",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6293923160567365123,39,2016
Renal vasculitis—an update in 2004,"AD Booth, CD Pusey, DR Jayne","Nephrology Dialysis Transplantation 19 (8), 1964-1968",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15610338724640320185,38,2004
2019 European League against Rheumatism/American College of rheumatology classification criteria for systemic lupus erythematosus,"M Aringer, K Costenbader, D Daikh, R Brinks, M Mosca, ...","Annals of the rheumatic diseases 78 (9), 1151-1159",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6260768519682680447,37,2019
Explaining fatigue in ANCA-associated vasculitis,"N Basu, A McClean, L Harper, EN Amft, N Dhaun, RA Luqmani, MA Little, ...","Rheumatology 52 (9), 1680-1685",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13311994441254948329,37,2013
Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?,"O Flossmann, RB Jones, DRW Jayne, RA Luqmani","Annals of the rheumatic diseases 65 (7), 841-844",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10221902115184925211,37,2006
Randomised controlled trial of daily oral versus pulse cyclophosphamide for induction of remission in ANCA-associated systemic vasculitis,"K De Groot, DRW Jayne, V Tesar, COS Savage","Kidney & Blood Pressure Research 28 (3), 195-195",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10682687138981087847,37,2005
Impact of rituximab trials on the treatment of ANCA-associated vasculitis,"F Alberici, DRW Jayne","Nephrology Dialysis Transplantation 29 (6), 1151-1159",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4438857450633057314,36,2013
Role of rituximab therapy in glomerulonephritis,D Jayne,"Journal of the American Society of Nephrology 21 (1), 14-17",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14989196109585044690,36,2010
What is new in the therapy of ANCA-associated vasculitides?,"K De Groot, D Jayne",Clinical nephrology 64 (6),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4353356635214487576,36,2005
Diagnosis and treatment of kidney disease,"J Cross, D Jayne","Best practice & research Clinical rheumatology 19 (5), 785-798",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=482787262850777315,36,2005
Long-term follow-up of cyclophosphamide compared with azathioprine for initial maintenance therapy in ANCA-associated vasculitis,"M Walsh, M Faurschou, A Berden, O Flossmann, I Bajema, P Hoglund, ...","Clinical Journal of the American Society of Nephrology 9 (9), 1571-1576",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14359377094837090864,35,2014
Randomised trial of cyclophosphamide versus azathioprine during remission in ANCA associated systemic vasculitis (CYCAZAREM).,"D Jayne, G Gaskin","Clinical and Experimental Immunology, Supplement 120",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13486148116670745755,35,2000
"Wegener's granulomatosis, subglottic stenosis and antineutrophil cytoplasm antibodies.","TJ Hoare, D Jayne, PR Evans, CB Croft, DJ Howard","The Journal of Laryngology & Otology 103 (12), 1187-1191",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2629787589084446563,35,1989
Lupus nephritis,"GB Appel, D Jayne","Floege J, Johnson RJ, Feehaly J. Comprehensive Clinical Nephrology. 4thed …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3987423986990392145,34,2010
How to induce remission in primary systemic vasculitis,D Jayne,"Best Practice & Research Clinical Rheumatology 19 (2), 293-305",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15141469343561435626,34,2005
Hurdles to the introduction of new therapies for immune-mediated kidney diseases,"HJ Anders, DRW Jayne, BH Rovin","Nature Reviews Nephrology 12 (4), 205",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15261244195441719548,33,2016
Long-term treatment of relapsing Wegener’s granulomatosis with 15-deoxyspergualin,"O Floßmann, DRW Jayne","Rheumatology 49 (3), 556-562",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11032719984501788296,33,2009
Assessment of damage in vasculitis: expert ratings of damage,"P Seo, D Jayne, R Luqmani, PA Merkel","Rheumatology 48 (7), 823-827",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13955531459120564863,33,2009
Conventional treatment and outcome of Wegener's granulomatosis and microscopic polyangiitis,DRW Jayne,"Cleveland Clinic journal of medicine 69, SII-110",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4623566586167904501,33,2002
Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity?,"S Furuta, C Cousins, A Chaudhry, D Jayne","The Journal of rheumatology 42 (2), 300-308",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10389504096767834469,32,2015
Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts,"C Pagnoux, S Carette, NA Khalidi, M Walsh, TF Hiemstra, D Cuthbertson, ...","Clinical and experimental rheumatology 33 (2 0 89), S",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1504838170112272012,31,2015
Anti–B cell antibody therapies for inflammatory rheumatic diseases,"M Faurschou, DRW Jayne","Annual review of medicine 65, 263-278",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16867793916693638431,31,2014
"Structured clinical assessment of the ear, nose and throat in patients with granulomatosis with polyangiitis (Wegener’s)","MM Del Pero, N Rasmussen, A Chaudhry, P Jani, D Jayne","European Archives of Oto-Rhino-Laryngology 270 (1), 345-354",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15427176570526017074,31,2013
The role of biologic therapies in the management of systemic vasculitis,"AT Chan, O Flossmann, C Mukhtyar, DRW Jayne, RA Luqmani","Autoimmunity reviews 5 (4), 273-278",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12199840944149053905,31,2006
Current attitudes to the therapy of vasculitis,D Jayne,"Kidney & blood pressure research 26 (4), 231",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3732679296217263590,31,2003
"Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial","RB Jones, TF Hiemstra, J Ballarin, DE Blockmans, P Brogan, A Bruchfeld, ...","Annals of the rheumatic diseases 78 (3), 399-405",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4832506870413517477,30,2019
Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis,"N Basu, A McClean, L Harper, EN Amft, N Dhaun, RA Luqmani, MA Little, ...","Rheumatology 53 (5), 953-956",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2151051462942331858,30,2014
Practice pattern variation in oral glucocorticoid therapy after the induction of response in proliferative lupus nephritis,"M Walsh, D Jayne, L Moist, M Tonelli, N Pannu, B Manns","Lupus 19 (5), 628-633",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14839843142301945352,30,2010
Analysis of anti-idiotypic antibodies against anti-microsomal antibodies in patients with thyroid autoimmunity,"N Tandon, DRW Jayne, AM McGregor, AP Weetman","Journal of autoimmunity 5 (5), 557-570",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3088000560787224267,30,1992
Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized …,"S Gopaluni, RM Smith, M Lewin, CA McAlear, K Mynard, RB Jones, ...","Trials 18 (1), 112",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12741770012841502218,29,2017
End-stage renal disease in ANCA-associated vasculitis,"S Moiseev, P Novikov, D Jayne, N Mukhin","Nephrology Dialysis Transplantation 32 (2), 248-253",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5592426328657175420,29,2016
LB0003 a randomized controlled study of laquinimod in active lupus nephritis patients in combination with standard of care,"D Jayne, G Appel, TM Chan, H Barkay, R Weiss, D Wofsy","Annals of the Rheumatic Diseases 72 (Suppl 3), A164-A164",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16099299939930756284,29,2013
Sequential antineutrophil cytoplasm antibody titers in management of systemic vasculitis,D Jayne,"Nephrol Dial Transplant 5, 309-310",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7860181940704797364,29,1990
3-D printouts of the tracheobronchial tree generated from CT images as an aid to management in a case of tracheobronchial chondromalacia caused by relapsing polychondritis,"MD Tam, SD Laycock, D Jayne, J Babar, B Noble","Journal of radiology case reports 7 (8), 34",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5525877206463423678,28,2013
Acquired hemophilia in association with ANCA-associated vasculitis: response to rituximab,"MR Clatworthy, DRW Jayne","American journal of kidney diseases 47 (4), 680-682",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15794808706025018292,28,2006
Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss),"V Cottin, E Bel, P Bottero, K Dalhoff, M Humbert, R Lazor, RA Sinico, ...","European Respiratory Journal 48 (5), 1429-1441",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3207802394154623746,27,2016
Characteristics and outcomes of granulomatosis with polyangiitis (Wegener) and microscopic polyangiitis requiring renal replacement therapy: results from the European Renal …,"Z Hruskova, VS Stel, D Jayne, K Aasarød, J De Meester, A Ekstrand, ...","American Journal of Kidney Diseases 66 (4), 613-620",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17993005994901620072,27,2015
The pulmonary vasculitides,"SK Frankel, D Jayne","Clinics in chest medicine 31 (3), 519-536",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10990793976550464188,27,2010
Severe infection in antineutrophil cytoplasmic antibody-associated vasculitis,"AJ Mohammad, M Segelmark, R Smith, M Englund, JÅ Nilsson, ...","The Journal of rheumatology 44 (10), 1468-1475",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=359908660502486972,26,2017
Pulmonary involvement in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: the influence of ANCA subtype,"AJ Mohammad, KH Mortensen, J Babar, R Smith, RB Jones, D Nakagomi, ...","The Journal of rheumatology 44 (10), 1458-1467",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8197392628946991758,25,2017
Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab,"S Shah, Z Hruskova, M Segelmark, MD Morgan, J Hogan, SK Lee, J Dale, ...","American journal of nephrology 41 (4-5), 296-301",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=29739060834525962,25,2015
Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS,"R Jones, JWC Tervaert, T Hauser, R Luqmani, CAU Peh, C Savage, ...",Apmis 117,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9170797197771681353,25,2009
Anti-idiotype antibodies to anti-myeloperoxidase autoantibodies in patients with systemic vasculitis,"DRW Jayne, VLM Esnault, CM Lockwood","Journal of autoimmunity 6 (2), 221-226",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4325343949983118761,25,1993
Alemtuzumab as remission induction therapy in Behçet disease: a 20-year experience,"AJ Mohammad, RM Smith, YW Chow, AN Chaudhry, DRW Jayne","The Journal of rheumatology 42 (10), 1906-1913",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9242181683493448858,24,2015
Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis,"SP McAdoo, N Medjeral-Thomas, S Gopaluni, A Tanna, N Mansfield, ...","Nephrology Dialysis Transplantation 34 (1), 63-73",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12471935995505499705,23,2018
Rituximab for immunologic renal disease: what the nephrologist needs to know,"A Kronbichler, M Windpessl, H Pieringer, DRW Jayne","Autoimmunity reviews 16 (6), 633-643",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12914784123525002652,23,2017
Elicitation of expert prior opinion: application to the MYPAN trial in childhood polyarteritis nodosa,"LV Hampson, J Whitehead, D Eleftheriou, C Tudur-Smith, R Jones, ...","PLoS One 10 (3), e0120981",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12252256203199115471,23,2015
Parvovirus B19 microepidemic in renal transplant recipients with thrombotic microangiopathy and allograft vasculitis.,"MR Ardalan, MM Shoja, RS Tubbs, D Jayne",Experimental and clinical transplantation: official journal of the Middle …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13156873607872175469,23,2008
Pulmonary-renal syndrome,D Jayne,"Seminars in respiratory and critical care medicine 19 (01), 69-77",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13919536640599030734,23,1998
The effects of plasma exchange and reduced-dose glucocorticoids during remission-induction for treatment of severe ANCA-associated vasculitis,"M Walsh, PA Merkel, D Jayne",ARTHRITIS & RHEUMATOLOGY 70,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8817710372946653900,22,2018
Con: Should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab?,"A Kronbichler, DRW Jayne","Nephrology Dialysis Transplantation 30 (7), 1075-1081",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18060329582434674370,22,2015
A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe,"T Ito-Ihara, E Muso, S Kobayashi, K Uno, N Tamura, Y Yamanishi, ...","Clinical & Experimental Rheumatology 26 (6), 1027",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9312653505151850178,22,2008
Rituximab for treatment of severe renal disease in ANCA associated vasculitis,"D Geetha, Z Hruskova, M Segelmark, J Hogan, MD Morgan, T Cavero, ...","Journal of nephrology 29 (2), 195-201",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16448942747576721220,21,2016
"Prevalence and Responsiveness to Treatment of Lung Abnormalities on Chest Computed Tomography in Patients With Microscopic Polyangiitis: A Multicenter, Longitudinal …","M Yamagata, K Ikeda, K Tsushima, K Iesato, M Abe, T Ito, ...","Arthritis & Rheumatology 68 (3), 713-723",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3488127658809080266,21,2016
Outcome assessment in Takayasu arteritis,"D Nakagomi, D Jayne","Rheumatology 55 (7), 1159-1171",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3445734066358768434,21,2015
Rituximab for ANCA-associated vasculitis in the setting of severe infection,"JW Gregersen, A Chaudhry, DRW Jayne","Scandinavian journal of rheumatology 42 (3), 207-210",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18399811513046380306,21,2013
EULAR recommendations for monitoring systemic lupus erythematosus patients in clinical practice and in observational studies,"M Mosca, C Tani, M Aringer, S Bombardieri, D Boumpas, R Brey, ...","Annals of the Rheumatic Diseases, ard. 2009.117200",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17940022962239582418,21,2009
Long-term outcome of airway stenosis in granulomatosis with polyangiitis (Wegener granulomatosis): an observational study,"MM Del Pero, D Jayne, A Chaudhry, P Sivasothy, P Jani","JAMA Otolaryngology–Head & Neck Surgery 140 (11), 1038-1044",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16664525742856439039,19,2014
Emerging therapies in antineutrophil cytoplasm antibody-associated vasculitis,"S Furuta, D Jayne","Current opinion in rheumatology 26 (1), 1-6",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14471870992182470034,19,2014
Switching of anti-TNF-α agents in Behçet's disease,"S Furuta, YW Chow, AN Chaudhry, D Jayne","Clinical and Experimental Rheumatology-Incl Supplements 30 (3), S62",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6785633774113883345,19,2012
What place for the new biologics in the treatment of necrotising vasculitides,D Jayne,"Clinical and experimental rheumatology 24 (2), S1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14217838960470026136,19,2006
Chronic nasal Staphylococcus aureus carriage identifies a subset of newly diagnosed granulomatosis with polyangiitis patients with high relapse rate,"A Salmela, N Rasmussen, JWC Tervaert, DRW Jayne, A Ekstrand","Rheumatology 56 (6), 965-972",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16588529045839154288,18,2017
Twenty-five years of European Union collaboration in ANCA-associated vasculitis research,"D Jayne, N Rasmussen","Nephrology Dialysis Transplantation 30 (suppl_1), i1-i7",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1132867875776475940,18,2015
Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data,"AAE de Joode, JSF Sanders, X Puéchal, LP Guillevin, TF Hiemstra, ...","Rheumatology 56 (11), 1894-1901",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10278558370962047937,17,2017
Biological therapy for lupus nephritis—tribulations and trials,"RM Smith, MR Clatworthy, DRW Jayne","Nature Reviews Rheumatology 6 (9), 547",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8542968104290506876,17,2010
Treatment of ANCA‐associated systemic small‐vessel vasculitis,D Jayne,"Apmis 117, 3-9",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9853345813513207063,17,2009
Mycophenolate mofetil and intravenous cyclophosphamide in the Aspreva Lupus Management Study (ALMS): efficacy by racial group,"EM Ginzler, GB Appel, MA Dooley, D Isenberg, D Jayne, N Solomons, ...","Arthritis and Rheumatism 56 (12), 4308-4308",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17989399313561113979,17,2007
Long-term follow-up of relapsing/refractory ANCA associated vasculitis treated with the lymphocyte depleting antibody alemtuzumab (CAMPATH-1H),"M Walsh, A Chaudhry, DRW Jayne",Annals of the Rheumatic Diseases,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=332216946531799519,17,2007
Current management of lupus nephritis: popular misconceptions,D Jayne,"Lupus 16 (3), 217-220",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12364189687577534480,17,2007
Branch retinal arteriolar occlusion associated with familial factor V Leiden polymorphism and positive rheumatoid factor,"S Dhar-Munshi, WH Ayliffe, D Jayne","Archives of Ophthalmology 117 (7), 978-979",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13860718853103606282,17,1999
The specificity of anti‐neutrophil cytoplasm autoantibodies in systemic vasculitides,"KN Lai, DRW Jayne, A Brownlee, CM Lockwood","Clinical & Experimental Immunology 82 (2), 233-237",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1180204529277971702,17,1990
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register,"EM McCarthy, E Sutton, S Nesbit, J White, B Parker, D Jayne, B Griffiths, ...","Rheumatology 57 (3), 470-479",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1852993021972878292,16,2017
Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse,"MD Morgan, M Szeto, M Walsh, D Jayne, K Westman, N Rasmussen, ...","Arthritis research & therapy 19 (1), 129",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2956576649728746351,16,2017
Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab,"D Geetha, C Kallenberg, JH Stone, AD Salama, GB Appel, G Duna, ...","Journal of nephrology 28 (1), 17-27",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3638740807241299277,16,2015
Targeting the B cell in vasculitis,"M Walsh, D Jayne","Pediatric Nephrology 24 (7), 1267-1275",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3758153185864386103,16,2009
Newer therapies for vasculitis,"TF Hiemstra, D Jayne","Best practice & research Clinical rheumatology 23 (3), 379-389",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9834198836372144497,16,2009
European collaborative trials in vasculitis: EUVAS-update and latest results,DR Jayne,"Clin Exp Immunol 120, 13-15",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11859441089190284728,16,2000
Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus,"SK Tedeschi, SR Johnson, DT Boumpas, D Daikh, T Dörner, B Diamond, ...","Annals of the rheumatic diseases 78 (5), 634-640",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10060906854474712030,15,2019
Trimethoprim–sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis,"A Kronbichler, J Kerschbaum, S Gopaluni, J Tieu, F Alberici, RB Jones, ...","Annals of the rheumatic diseases 77 (10), 1440-1447",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8581716328915768549,15,2018
"Development of a score for assessment of radiologic damage in large-vessel vasculitis (Combined Arteritis Damage Score, CARDS)","D Nakagomi, C Cousins, J Sznajd, S Furuta, AJ Mohammad, R Luqmani, ...",Clinical and Experimental Rheumatology,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4030489022573432481,15,2018
OP0020 Validation of new systemic lupus erythematosus classification criteria,"M Aringer, KH Costenbader, R Brinks, D Boumpas, D Daikh, D Jayne, ...","Annals of the rheumatic diseases 77 (Suppl 2), 60-60",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14019695018908115415,15,2018
A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis,"R López-Mejías, FD Carmona, S Castañeda, F Genre, ...","Scientific reports 7 (1), 5088",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14120087683815566000,15,2017
Comparison of the phenotype and outcome of granulomatosis with polyangiitis between UK and Japanese cohorts,"S Furuta, AN Chaudhry, Y Arimura, H Dobashi, S Fujimoto, S Homma, ...","The Journal of rheumatology 44 (2), 216-222",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9622425967775460644,15,2017
Plasma exchange induces vitamin D deficiency,"TF Hiemstra, A Casian, P Boraks, DR Jayne, I Schoenmakers","QJM: An International Journal of Medicine 107 (2), 123-130",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16832024535098179857,15,2013
A disease activity score for ENT involvement in granulomatosis with polyangiitis (Wegener's),"M Martinez Del Pero, A Chaudhry, N Rasmussen, P Jani, D Jayne","The Laryngoscope 123 (3), 622-628",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9165728482041579560,15,2013
Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein),"F Maritati, R Fenoglio, E Pillebout, G Emmi, ML Urban, R Rocco, ...","Arthritis & Rheumatology 70 (1), 109-114",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15547344602654491297,14,2018
Lupus nephritis and B-cell targeting therapy,"M Cassia, F Alberici, M Gallieni, D Jayne","Expert review of clinical immunology 13 (10), 951-962",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16385101131272151889,14,2017
Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody–associated vasculitis,"F Alberici, RM Smith, M Fonseca, LC Willcocks, RB Jones, JU Holle, ...","Journal of Allergy and Clinical Immunology 139 (5), 1684-1687. e10",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3044230006128948324,14,2017
A historical essay on detection of anti-neutrophil cytoplasmic antibodies,"N Rasmussen, A Wiik, DR Jayne","Nephrology Dialysis Transplantation 30 (suppl_1), i8-i13",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6824269255649441614,14,2015
"Renal function and ear, nose, throat involvement in anti-neutrophil cytoplasmic antibody-associated vasculitis: prospective data from the European Vasculitis Society clinical …","C Rahmattulla, RAF de Lind van Wijngaarden, AE Berden, HA Hauer, ...","Rheumatology 54 (5), 899-907",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1625049533548596431,14,2014
Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener’s) may reflect treatment rather than disease …,"N Rasmussen, A Salmela, A Ekstrand, K de Groot, G Gregorini, ...","Clin Exp Rheumatol 31 (Suppl 75), S38-44",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15587316894558423558,14,2013
Long-term damage to the ENT system in Wegener’s granulomatosis,"MM Del Pero, M Walsh, R Luqmani, O Flossmann, C Mukhtyar, P Jani, ...","European Archives of Oto-rhino-laryngology 268 (5), 733-739",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6734624292844574964,14,2011
Randomized trial of mycophenolate mofetil vs azathioprine for maintenance therapy in ANCA-associated vasculitis (IMPROVE),"T Hiemstra, M Walsh, K De Groot, T Hauser, A Mahr, C Pagnoux, L Harper, ...","Apmis 117, 77-78",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=669619421231319391,14,2009
Mycophenolate mofetil in lupus nephritis,"J Cross, D Jayne","Lupus 9 (9), 647-650",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5511751468091484614,14,2000
Anti‐mitochondrial antibody IgG subclass distribution and affinity in primary biliary cirrhosis,"L Zhang, AP Weetman, DRW Jayne, I Turner, SJ Yeaman, ...","Clinical & Experimental Immunology 88 (1), 56-61",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2136962848090735426,14,1992
A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody–associated vasculitis,"RJ Pepper, SP McAdoo, SM Moran, D Kelly, J Scott, S Hamour, A Burns, ...","Rheumatology 58 (2), 260-268",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11718983953355658833,13,2019
ANCA-associated glomerulonephritis: risk factors for renal relapse,"A Göçeroğlu, AE Berden, M Fiocco, O Floßmann, KW Westman, F Ferrario, ...","PloS one 11 (12), e0165402",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6573653422756836241,13,2016
OP0227 oral C5a receptor antagonist CCX168 Phase 2 clinical TRIAL in ANCA-associated renal vasculitis,"DR Jayne, A Bruchfeld, M Schaier, K Ciechanowski, L Harper, M Jadoul, ...","Annals of the Rheumatic Diseases 73 (Suppl 2), 148-148",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15250499329710264761,13,2014
Treating vasculitis with conventional immunosuppressive agents.,D Jayne,"Cleveland Clinic journal of medicine 79, S46-9",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3900543066580593706,13,2012
Rituximab treatment for vasculitis,D Jayne,"Clinical Journal of the American Society of Nephrology 5 (8), 1359-1362",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17761136942217144102,13,2010
A prospective-study of the incidence of anti-gbm and anti-neutrophil cytoplasm antibodies in patients with rapidly progressive nephritis,"CM Lockwood, DR Jayne, P Marshall, S Jones, COS Savage","KIDNEY INTERNATIONAL 33 (1), 329-329",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12730393538342067341,13,1988
Use of consensus methodology to determine candidate items for systemic lupus erythematosus classification criteria,"SR Johnson, D Khanna, D Daikh, R Cervera, N Costedoat-Chalumeau, ...","The Journal of rheumatology 46 (7), 721-726",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12826661219994571764,12,2019
Targeting B cells and plasma cells in glomerular diseases: translational perspectives,"E Schrezenmeier, D Jayne, T Dörner","Journal of the American Society of Nephrology 29 (3), 741-758",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2109135343523670782,12,2018
Gusperimus: immunological mechanism and clinical applications,"M Perenyei, DRW Jayne, O Floßmann","Rheumatology 53 (10), 1732-1741",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4953978224793880786,12,2014
Isolated large vessel pulmonary vasculitis as a cause of chronic obstruction of the pulmonary arteries,"G Hagan, D Gopalan, C Church, D Rassl, C Mukhtyar, T Wistow, C Lang, ...","Pulmonary circulation 1 (3), 425-429",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3225635215101641520,12,2011
B cell therapy in ANCA-associated vasculitis: current and emerging treatment options,"M McClure, S Gopaluni, D Jayne, R Jones","Nature Reviews Rheumatology 14 (10), 580-591","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8591900913847956928,7517199955389388579",11,2018
Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts,"M Yates, R Watts, I Bajema, M Cid, B Crestani, T Hauser, B Hellmich, ...","RMD open 3 (1), e000449",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11917977756023331789,11,2017
Clinical associations with venous thromboembolism in anti-neutrophil cytoplasm antibody-associated vasculitides,"A Kronbichler, J Leierer, G Leierer, G Mayer, A Casian, P Höglund, ...","Rheumatology 56 (5), 704-708",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15458358911299536288,11,2017
Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases,"SM Flint, V Jovanovic, BW Teo, A Mak, J Thumboo, EF McKinney, JC Lee, ...","RMD open 2 (1), e000183",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8270150972983094221,11,2016
D. Jayne,D Jayne,"Clinical and experimental rheumatology 25, S77-S79",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6579396730773530599,11,2007
"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in"" non-renal"" AbCA-associated vasculitis.","K De Groot, N Rasmussen, PA Bacon, JWC Tervaert, C Feighery, ...",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3575058095635040964,11,2003
"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in"" non-renal"" ANCA-associated vasculitis.","K De Groot, N Rasmussen, JWC Tervaert, D Jayne","Journal of the American Society of Nephrology 13, 2A-2A",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11757316716408644660,11,2002
CAMPATH 1-H (ANTI-CD52) for refractory vasculitis: retrospective Cambridge experience 1989-1999,DRW Jayne,"CLEVELAND CLINIC JOURNAL OF MEDICINE 69, SII-129",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18114359448255411621,11,2002
Venous thromboembolism with concurrent pulmonary haemorrhage in systemic vasculitis,"E De Sousa, R Smith, A Chaudhry, L Willcocks, D Jayne","Nephrology Dialysis Transplantation 27 (12), 4357-4361",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7649242908676259629,10,2012
Treatment of primary systemic vasculitis with the inosine monophosphate dehydrogenase inhibitor mycophenolic acid,"TF Hiemstra, RB Jones, DRW Jayne","Nephron Clinical Practice 116 (1), c1-c10",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4755925780902567869,10,2010
Translational research in autoimmunity: aims of therapy in vasculitis,"R Watts, L Harper, D Jayne, J Levy, C Pusey, C Savage, DGI Scott, ...","Rheumatology 44 (5), 573-576",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8731891648670413545,10,2005
Stem cell transplantation in systemic lupus erythematosus,D Jayne,"Best Practice & Research Clinical Haematology 17 (2), 291-304",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16659010740141286686,10,2004
Peripheral vasculopathy and nephropathy in association with phentermine.,"HJ Jefferson, DR Jayne","Nephrology, dialysis, transplantation: official publication of the European …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1498452441380723672,10,1999
Rasmussen N for the European Community Systemic Vasculitis Clinical Trials Study Group. Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis,DRW Jayne,"Mayo Clin. Proc. 72, 737-747",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=591875517074906584,10,1997
Anti-idiotype antibodies to anti-mitochondrial antibodies in the sera of patients with primary biliary cirrhosis,"L Zhang, DRW Jayne, DBG Oliveira","Journal of autoimmunity 6 (1), 93-105",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11677621881731192526,10,1993
Comparisons of Guidelines and Recommendations on Managing Antineutrophil Cytoplasmic Antibody–Associated Vasculitis,"D Geetha, Q Jin, J Scott, Z Hruskova, M Hanouneh, MA Little, V Tesar, ...","Kidney international reports 3 (5), 1039-1049",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17415553067292130797,9,2018
Hematuria and proteinuria,"D Jayne, V Yiu","National Kidney Foundation Primer on Kidney Diseases, 42",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13712012416885256466,9,2013
Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Randomized Controlled Study,"D Jayne, D Blockmans, R Luqmani, S Moiseev, B Ji, Y Green, L Hall, ...","Arthritis & Rheumatology 71 (6), 952-963",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5924717747627255392,8,2019
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis,"J Steinfeld, ES Bradford, J Brown, S Mallett, SW Yancey, P Akuthota, ...","Journal of Allergy and Clinical Immunology 143 (6), 2170-2177",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17902280483868909705,8,2019
A case of systemic nocardiosis in systemic vasculitis and a review of the literature.,"D Sirisena, LS Al, D Jayne, K Chakravarty","Singapore medical journal 54 (6), e127-30",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5443795529525666447,8,2013
Protocolized versus non-protocolized RTX treatment for refractory ANCA-AAV,"R Jones, R Smith, MJ Guerry, S Laurino, F Catapano, A Chaudhry, ...",Clinical and Experimental Immunology 164,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7147863790761180149,8,2011
Leflunomide versus methotrexate in Wegener's granulomatosis,D Jayne,"Oxford University Press 46 (7), 1047-1048",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17489688666068911349,8,2007
The clinical features and pathology of vasculitis associated with anti-myeloperoxidase autoantibodies,D Jayne,"Jpn J Infect Dis 57 (5), S16-S17",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7375316539748343118,8,2004
Comparison of disease activity measures for ANCA-associated vasculitis.,"PA Merkel, D Cuthbertson, B Hellmich, GS Hoffman, D Jayne, ...",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17002223473739533885,8,2004
The european vasculitis society 2016 meeting report,"IM Bajema, JA Bruijn, A Casian, MC Cid, E Csernok, E Van Daalen, ...","Kidney international reports 2 (6), 1018-1031",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1165348185617489458,7,2017
Efficacy and safety of belimumab in combination with azathioprine for remission maintenance in granulomatosis with polyangiitis and microscopic polyangiitis: a multicenter …,"D Jayne, D Blockmans, R Luqmani, B Ji, Y Green, L Hall, D Roth, ...",Wiley 69 (S10),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6409373364143085939,7,2017
Successful steroid replacement in ANCA-associated vasculitis with C5a receptor inhibitor CCX168 in phase 2 randomised trial (CLEAR),"D Jayne, A Bruchfeld, L Harper, M Schaier, M Venning, P Hamilton, ...","Nephrology, Dialysis, Transplantation",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18145650247514890257,7,2016
Sustained remission in lupus nephritis: still a hard road ahead,"LF Quintana, D Jayne","Nephrology Dialysis Transplantation 31 (12), 2011-2018",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12313883687472346077,7,2015
GLOMERULONEPHRITIDES,"DRW Jayne, A Bruchfeld, M Schaier, K Ciechanowski, L Harper, M Jadoul, ...","Nephrology Dialysis Transplanation 29 (suppl_3), iii27-iii29",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1088936375313273688,7,2014
New-generation therapy for ANCA-associated vasculitis,D Jayne,"Clinical and experimental nephrology 17 (5), 694-696",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2233944437030527246,7,2013
Immunotherapy for autoimmune and inflammatory renal diseases,"AD Booth, JD Firth, DRW Jayne","Expert opinion on biological therapy 3 (3), 487-500",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3814460181107444129,7,2003
Clinical management and treatment of vasculitis,D Jayne,"Springer seminars in immunopathology 23 (3), 267-286",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2570055646428859314,7,2001
Standard of treatment and outcomes of adults with lupus nephritis in Africa: a systematic review,"OI Ameh, AP Kengne, D Jayne, AK Bello, B Hodkinson, A Gcelu, ...","Lupus 25 (11), 1269-1277",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17497187834087184231,6,2016
Con: the use of calcineurin inhibitors in the treatment of lupus nephritis,"M Fernandez Nieto, DR Jayne","Nephrology Dialysis Transplantation 31 (10), 1567-1571",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17092355153874164684,6,2016
"The African Lupus Genetics Network (ALUGEN) registry: standardized, prospective follow-up studies in African patients with systemic lupus erythematosus","B Hodkinson, D Mapiye, D Jayne, A Kalla, N Tiffin, I Okpechi","Lupus 25 (3), 325-330",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10585370970599509474,6,2016
Surrogate end points in clinical trials: the case of anti-neutrophil cytoplasm antibody-associated vasculitis,"M Walsh, M Tonelli, D Jayne, B Manns","Journal of nephrology 20 (B), 119",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3867783884321194408,6,2007
Infliximab in ANCA-associated vasculitis: the ‘ACTIVE’trial,"A Booth, P Bacon, M Griffith, L Harper, T Hammad, J Levy, C Pusey, ...",Nephrology Dialysis Transplantation 18,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6170041172009790710,6,2003
P17: Review of the activities of the European vasculitis study group (EUVAS),"N Rasmussen, DRW Jayne","Clinical & Experimental Immunology, Supplement 112, 13-15",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4142201459898612902,6,1998
Intravenous immunoglobulin in the therapy of systemic vasculitis,DRW Jayne,"Transfusion Science 13 (3), 317-324",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7181913918001563088,6,1992
Clinical trials in vasculitis,"S Gopaluni, D Jayne","Current treatment options in rheumatology 2 (2), 161-177",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5545373418889719968,5,2016
Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease,"RB Jones, M Walsh, AN Chaudhry, KGC Smith, DRW Jayne","Clinical kidney journal 7 (6), 562-568",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3014071904646590160,5,2014
OP0064 Joint EULAR/ERA-EDTA recommendations for the management of adult and pediatric lupus nephritis,"G Bertsias, M Tektonidou, Z Amoura, M Aringer, I Bajema, J Berden, ...","Annals of the Rheumatic Diseases 71 (Suppl 3), 74-75",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5487216631094116775,5,2013
A multicenter survey of rituximab for eosinophilic granulomatosis with polyangiitis (Churg-Strauss),"A Hot, MJ Guerry, R Smith, P Sivasothy, L Guillevin, P Merkel, D Jayne","La Presse Médicale 42 (4P2), 698",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4361120037828197219,5,2013
"Signatures of CD4 T-cell help and CD8 exhaustion predict clinical outcome in autoimmunity, infection, and vaccination","EF McKinney, J Lee, PA Lyons, TF Rayner, EJ Carr, A Hatton, DRW Jayne, ...","The Lancet 381, S74",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14239630417001844985,5,2013
Current modalities in the diagnosis of pulmonary vasculitis,"A Casian, D Jayne","Expert opinion on medical diagnostics 6 (6), 499-516",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15185561617353507946,5,2012
Maintaining remission in a patient with vasculitis,"O Flossmann, DRW Jayne","Nature Reviews Rheumatology 4 (9), 499",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6940224590937693365,5,2008
Incidence of non-fatal clinical coronary events in primary ANCA-associated systemic vasculitis (aasv),"EM Salisbury, JS McLaren, SK Pathare, DRW Jayne, RA Luqmani",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7035552398567472546,5,2003
Specific MPO immunoabsorption for the treatment of vasculitis.,"S Alexandre, N Moguilevsky, P Paindavoine, P D'Ippolito, D Demaret, ...","Clinical and Experimental Immunology, Supplement 120",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1808976562735738817,5,2000
Immunoglobulin replacement for secondary immunodeficiency after B-cell targeted therapies in autoimmune rheumatic disease: systematic literature review,"S Wijetilleka, C Mukhtyar, D Jayne, A Ala, P Bright, H Chinoy, L Harper, ...",Autoimmunity reviews,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4872477159746207066,4,2019
Comment on: Rituximab therapy for Takayasu arteritis: a seven patients experience and a review of the literature,"D Nakagomi, A Kronbichler, T Witte, AJ Mohammad, DRW Jayne","Rheumatology 57 (7), 1309-1310",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6560325628842613496,4,2018
P1_185 The Steroid Tapering in ANCA Vasculitis Evaluation Study (STAVE) 2: a Systematic Review and Meta-Analysis,"JC Rodrigues, D Collister, A Archer, K Cheema, P Alexander, C Pagnoux, ...","Rheumatology 56 (suppl_3), iii103-iii103",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14455254774202182843,4,2017
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis,"R Jones, S Furuta, JW Tervaert, T Hauser, R Luqmani, M Morgan, C Peh, ...","Annals of the Rheumatic Diseases 74 (6), 1178-1182",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8823395860753510690,4,2015
Extending the indications for rituximab in ANCA-associated vasculitis,D Jayne,"New England Journal of Medicine 371 (19), 1839-1840",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11279842603175178357,4,2014
Elicitation of expert prior opinion: application to the mypan trial in childhood polyarteritis nodosa,"L Hampson, J Whitehead, D Eleftheriou, C Tudur-Smith, R Jones, ...","Pediatric Rheumatology 12 (1), P125",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5973743817103579747,4,2014
New biologics for glomerular disease on the horizon,"A Karras, D Jayne","Nephron Clinical Practice 128 (3-4), 283-291",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=869309121725710398,4,2014
S2. Rituximab for ANCA-associated vasculitis: The UK experience,D Jayne,Elsevier Masson,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17155308772966735670,4,2013
L27. Antibodies versus phenotypes: A clinician’s view,D Jayne,"La Presse Médicale 42 (4P2), 579-582",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13295443666919201963,4,2013
The clinical presentation and treatment of renal vasculitis,D Jayne,"Rheumatology and the kidney. Adu D, Emery P, Madaio M, eds. Oxford: Oxford …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15335006573168827359,4,2012
Risk factors for relapse of ANCA associated vasculitis.,"M Walsh, O Floßmann, A Berden, K Westman, P Höglund, C Stegeman, ...",Arthritis and rheumatism,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1995618902513376770,4,2011
Long-term survival of ANCA-associated vasculitis,"O Flossmann, A Berden, K De Groot, L Harper, C Heijl, P HÖGlund, ...",Apmis 117,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13167578242320517868,4,2009
Epidemiology of renal ANCA-associated vasculitis in the UK and Japan,"RA Watts, DGI Scott, S Fujimoto, S Kobayashi, K Suzuki, S Shigeto, ...","CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 25 (1), S95-S95",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17256314068333528868,4,2007
"Clinical manifestation, approach to diagnosis and treatment of pulmonary vasculitis","M Thomeer, PA Bacon, D Blockmans, X Bossuyt, M Galeazzi, D Jayne, ...","EUROPEAN RESPIRATORY MONOGRAPH 34, 69",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7053157671630161557,4,2005
Intravenous pulse versus oral administration of cyclophosphamide: comment on the article by Haubitz et al,"COS Savage, DRW Jayne",Arthritis & Rheumatism: Official Journal of the American College of …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17511209070114691487,4,1999
P16: Immunotherapy for ANCA-associated systemic vasculitis,DRW Jayne,"Clinical & Experimental Immunology, Supplement 112, 12-13",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16544584602605699805,4,1998
High-dose pooled immunoglobulin in the therapy of systemic vasculitis.,"DR Jayne, CM Lockwood","Transactions of the Association of American Physicians 104, 304",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18070372219860376376,4,1991
Sequential ANCA and C‐reactive protein estimations in the management of systemic vasculitis,"DRW Jayne, A Heaton, DB Evans, CM Lockwood","Apmis 98 (S19), 44-44",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1969104862098092159,4,1990
ANCA and systemic vasculitis.,"CM Lockwood, SJ Jones, DR Jayne, KN Lai","The Netherlands journal of medicine 36 (3-4), 154",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13703245185781254326,4,1990
Subclassifying ANCA-associated vasculitis: a unifying view of disease spectrum,"A Mahr, U Specks, D Jayne",Rheumatology,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7887568456784593020,3,2019
Effect of Disease Activity at Three and Six Months After Diagnosis on Long‐Term Outcomes in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis,"S Gopaluni, O Flossmann, MA Little, P O'Hara, P Bekker, D Jayne, ...","Arthritis & Rheumatology 71 (5), 784-791",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10494475998457845691,3,2019
"Refractory lupus nephritis: When, why and how to treat","A Kronbichler, B Brezina, P Gauckler, LF Quintana, DRW Jayne",Autoimmunity reviews,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13504187970266515475,3,2019
Genetic Variants in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Bayesian Approach and Systematic Review,"KS Lee, A Kronbichler, DF Pereira Vasconcelos, FR Pereira da Silva, ...","Journal of clinical medicine 8 (2), 266",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5279926233787057242,3,2019
Efficacy and safety of belimumab and azathioprine for maintenance of remission in ANCA-associated vasculitis: a randomized controlled study,"D Jayne, D Blockmans, R Luqmani, S Moiseev, B Ji, Y Green, L Hall, ...",Arthritis and Rheumatology 71 (6),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17101554018841199575,3,2019
Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseases,"S Wijetilleka, DR Jayne, C Mukhtyar, A Ala, PD Bright, H Chinoy, L Harper, ...","Rheumatology 58 (5), 889-896",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1589687657231230630,3,2018
"Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome","MAC Wester Trejo, O Floßmann, KW Westman, P Höglund, EC Hagen, ...","Rheumatology 58 (1), 103-109",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15518632122230813,3,2018
"OP0253 A phase iii randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of abatacept or placebo on standard of care in patients with active …","R Furie, MA Dooley, D Wofsy, T Takeuchi, A Malvar, A Doria, ...","Annals of the Rheumatic Diseases 77 (Suppl 2), 176-177",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16635975633845095156,3,2018
LB01 THE EFFECT OF PLASMA EXCHANGE ON END STAGE RENAL DISEASE AND DEATH IN PATIENTS WITH SEVERE ANCA ASSOCIATED VASCULITIS,"M Walsh, P Merkel, CA Peh, W Szpirt, X Puéchal, S Fujimoto, C Hawley, ...","Nephrology Dialysis Transplantation 33 (suppl_1), i636-i636",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5116552399499381179,3,2018
"Genetically distinct clinical subsets, and associations with asthma and eosinophil abundance, within Eosinophilic Granulomatosis with Polyangiitis","P Lyons, J Peters, F Alberici, J Liley, R Coulson, W Astle, C Baldini, ...","bioRxiv, 491837",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9377532501613281754,3,2018
Vasculitis—when can biopsy be avoided?,D Jayne,"Nephrology Dialysis Transplantation 32 (9), 1454-1456",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=134703720871464098,3,2017
Efficacy of rituximab in Takayasu arteritis: a case series,"D Nakagomi, A Kronbichler, T Witte, AJ Mohammad, D Jayne","Rheumatology 56, 51-+",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13341366856827037337,3,2017
Use of nominal group technique to determine candidate items for sle classification criteria development,"SR Johnson, D Khanna, R Cervera, N Costedoat-Chalumeau, ...",ARTHRITIS & RHEUMATOLOGY 68,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6746966345536335785,3,2016
"CCX168, an Orally Administered C5aR Inhibitor for Treatment of Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.: 1863","P Bekker, D Jayne, A Bruchfeld, M Schaier, K Ciechanowski, L Harper, ...",Arthritis & Rheumatology 66,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6956878713018607062,3,2014
PEXIVAS: design of an RCT of PLEX and GC dosing in the treatment of severe ANCA-AAV,"M Walsh, P Merkel, A Casian, D Jayne",Clinical and Experimental Immunology 164,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11387198634129379899,3,2011
Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus,"C Mukhtyar, D Boumpas, C Gordon, W Gross, D Jayne, R Luqmani","Annals of the rheumatic diseases 66 (5), 569-570",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13656893864920977284,3,2007
Adjunctive plasma exchange is superior to methylprednisolone in acute renal failure due to ANCA-associated glomerulonephritis.,"RA Luqmani, D Jayne, G Gaskin",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11551718090487252522,3,2002
Validation of the Birmingham Vasculitis Activity Score (BVAS) for use in European multi-centre clinical trials.,"RA Luqmani, PA Bacon, N Rasmussen, D Jayne",ARTHRITIS AND RHEUMATISM 43 (9),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15217975494356312252,3,2000
Immunotherapy for autoimmune and inflammatory renal diseases.,DR Jayne,"Current opinion in nephrology and hypertension 7 (3), 311-315",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2257846610874192400,3,1998
New strategies for plasma exchange in systemic vasculitis,DRW Jayne,"Transfusion science 11 (3-4), 263-269",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11261635006702787601,3,1990
SEVERE PULMONARY HEMORRHAGE AND SYSTEMIC VASCULITIS IN ASSOCIATION WITH ISOLATED CIRCULATING IGM ANTI-NEUTROPHIL ANTIBODY,"DRW Jayne, SJ Jones, CM Lockwood","KIDNEY INTERNATIONAL 33 (1), 328-328",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2929617002453100723,3,1988
EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: Focus on ANCA-associated vasculitis,"B Hellmich, O Flossmann, WL Gross, P Bacon, J Willem, ...",Pulmonary hemorrhage in ESRD of ANCA vasculitis Chapter 8,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2541307243985886204,3,0
Analysis of the B cell receptor repertoire in six immune-mediated diseases,"RJM Bashford-Rogers, L Bergamaschi, EF McKinney, DC Pombal, ...","Nature 574 (7776), 122-126",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16440075700328299518,2,2019
Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis,"V Teixeira, AJ Mohammad, RB Jones, R Smith, D Jayne","RMD Open 5 (1), e000905",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17852375302888391146,2,2019
360. The effect of plasma exchange on end-stage renal disease and death in patients with severe ANCA-associated vasculitis,"M Walsh, P Merkel, D Jayne, PEXIVAS Investigators","Rheumatology 58 (Supplement_2), kez063. 084",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3524123535503298187,2,2019
ANCA Renal Risk Score: is prediction of end-stage renal disease at baseline possible?,"A Kronbichler, DRW Jayne","Kidney international 94 (6), 1045-1047",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14527897776701021251,2,2018
A case of ,"C Conduit, S Yew, MD Jose, D Jayne, G Kirkland","Internal medicine journal 47 (5), 600-601",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12671386922895946598,2,2017
TO037 CLINICAL PREDICTORS OF RESPONSE TO RITUXIMAB IN ANCA-ASSOCIATED VASCULITIS: A EUROPEAN COHORT,"F Alberici, R Smith, M Cassia, F Colombo, I Brenna, R Jones, J Holle, ...","Nephrology Dialysis Transplantation 31 (suppl_1), i77-i77",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18169544036154655486,2,2016
Lupus nephropathy and vasculitis,"L Willcocks, R Jones, D Jayne","Medicine 43 (9), 538-544",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18004449832939846797,2,2015
O15. Response to Rituximab in Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multi-Centre Register,"EJ Sutton, KD Watson, DA Isenberg, A Rahman, D Jayne, C Gordon, ...","Rheumatology 54 (suppl_1), i30-i31",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10737720223297208332,2,2015
334. UK & Ireland Vasculitis Registry (UKIVAS): cross-sectional data on the first 556 patients,"J Sznajd, AD Salama, D Jayne, A Chaudhry, M Robson, J Rosa, J Barrett, ...","Rheumatology 53 (suppl_1), i184-i185",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11220036278154592663,2,2014
Renal vasculitis,"L Manenti, L Signorini, E Gnappi, FP Pilato, A Vaglio, L Allegri, C Buzio, ...","Nephrology Dialysis Transplantation 28 (suppl_1), i1-i2",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5985992931431482074,2,2013
"Clinical nephrology-IgA nephropathy, lupus nephritis, vasculitis","J Wu, S Duan, W Li, Y Wang, W Liu, J Zhang, L Lun, X Li, C Zhou, ...","Nephrology Dialysis Transplantation 28 (suppl_1), i175-i184",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5968940506473505239,2,2013
"An international, open label, randomised controlled trial comparing rituximab with azathioprine as maintenance therapy in relapsing ANCA-associated vasculitis (RITAZAREM)","D Jayne, R Smith, P Merkel","La Presse Médicale 42 (4P2), 768",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16415005587589222244,2,2013
Use of an empirically derived cyclophosphamide dosing nomogram for treatment of vasculitis,"A Salama, MD Gabrel, A Koteci, L Harper, D Jayne, D Nitsch, R Daniel, ...","La Presse Médicale 42 (4P2), 777-778",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12068968316135306487,2,2013
Basic science 232. Certolizumab pegol prevents pro-inflammatory alterations in endothelial cell function,"S Heathfield, B Parker, L Zeef, I Bruce, Y Alexander, F Collins, M Stone, ...","Rheumatology 51 (suppl_3), iii140-iii184","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18149992059020423367,3787220272589436237",2,2012
B cell depletion in systemic vasculitis,"R M Smith, D RW Jayne","Current Immunology Reviews 7 (4), 415-422",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5705851560904897671,2,2011
Lupus nephropathy and vasculitis,"L WiIlcocks, R Jones, D Jayne","Medicine 39 (8), 486-491",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16494980599156538662,2,2011
"Pulse versus daily oral CyP for induction of remission in ANCA-associated vasculitis. A European, multi-centre randomized controlled trial: long-term follow-up","L Harper, MD Morgan, O Flossman, K Westman, K de Groot, ...",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7653906241610400200,2,2011
Long-term renal outcome of patients enrolled in the CYCAZAREM trial,"A Berden, A Casian, K Westman, I Bajema, D Jayne",Clinical and Experimental Immunology 164,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3823093110628299673,2,2011
POI06 Rituximab in neuropsychiatric systemic lupus erythematosus: a retrospective study of the Cambridge experience,"M Zandi, F Catapano, S Burns, FC Hall, KGC Smith, DRW Jayne, ...","Journal of Neurology, Neurosurgery & Psychiatry 81 (11), e54-e54",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14053453499947120448,2,2010
Role of plasma exchange in the treatment of primary vasculitides,"AL Casian, DRW Jayne","International Journal of Clinical Rheumatology 5 (3), 339",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4786999791574169369,2,2010
Tolerance and safety of rituximab in vasculitis and SLE: A30,"F Catapano, W Michael, D Jayne","Apmis 117, 80-81",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16199453110517497693,2,2009
Plasma exchange in ANCA-associated vasculitis: a systematic review and meta-analysis,"M Walsh, F Catapano, W Szpirt, D Jayne",Apmis 117,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2945452340172511101,2,2009
Protocolized vs non-protocolized rituximab treatment for refractory ANCA-associated systemic vasculitis.,"R Jones, S Laurino, A Chaudhry, F Catapano, K Smith, D Jayne",Apmis 117,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1258579707435955011,2,2009
Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV),"C Mukhtyar, O Flomann, D Brown, K Westman, D Jayne, RA Luqmani","BSR Annual Meeting and BHPR Spring Meeting, 2008 47 (Suppl. 2), 7-7",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14802895938643250191,2,2008
Lupus nephropathy and vasculitis,"D Jayne, R Jones","medicine 35 (9), 516-520",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1611624974815160084,2,2007
B cell depletion with rituximab treatment for vasculitis,"R Jones, S Burns, K Smith, D Jayne","NEPHROLOGY DIALYSIS TRANSPLANTATION 21, 555-555",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5945191172166171137,2,2006
"A prospective, open label trial of B-cell depletion with Rituximab in refractory systemic vasculitis.","KGC Smith, DRW Jayne","JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 14, 755A-755A",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2877675060754760188,2,2003
Clinical nephrology-epidemiology-clinical trials: determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients,"H Hauer, I Bajema, H Van Houwelingen, F Ferrario, L Noël, R Waldherr, ...",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5587415576700496643,2,2002
Vasculitis assessment for clinical trials,"R Luqmani, D Jayne, J Thorogood, J Hermans, E Hagen, N Rasmussen","Clinical and Experimental Immunology, Supplement 120",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4278868229673531488,2,2000
New strategies in the treatment of systemic vasculitis.,"DR Jayne, CM Lockwood","Annales de medecine interne 145 (8), 595-600",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6972413942604120809,2,1994
The isotype distribution of ANCA in systemic vasculitis,"DRW Jayne, CM Lockwoood","Apmis 98 (S19), 45-45",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7015221102659164065,2,1990
Classification of vasculitis,D Jayne,,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5098360294598442947,2,1980
ANCA associated vasculitis: The journey to complement-targeted therapies,"LF Quintana, A Kronbichler, M Blasco, M Zhao, D Jayne","Molecular immunology 112, 394-398",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1010772827421482886,1,2019
Rituximab as maintenance treatment for systemic Lupus ErythematosusA multicentre observational study of 147 patients,"MA Cassia, F Alberici, RB Jones, RM Smith, G Casazza, ML Urban, ...",Arthritis & Rheumatology,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11513723252726981591,1,2019
The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritis,"P Mertz, A Belot, R Cervera, TY Chuah, L Dagna, L Damian, D Danda, ...","Joint Bone Spine 86 (3), 363-368",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7839200257113072192,1,2019
Plasma exchange as a novel treatment for IGA vasculitis with nephritis,"B Sanchez, A Egan, D Jayne, L Willcocks, R Jones",Rheumatology 58,"https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4161487626340428533,9150197928000456620",1,2019
Outcome of participants with nephrotic syndrome in combined clinical trials of lupus nephritis,"LM Gomez Mendez, MD Cascino, TR Katsumoto, P Brakeman, P Brunetta, ...",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15074662633706284649,1,2019
Systemic vasculitis and patient-reported outcomes: how the assessment of patient preferences and perspectives could improve outcomes,"JC Robson, D Jayne, PA Merkel, J Dawson","Patient related outcome measures 10, 37",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17313585602984012841,1,2019
Estimating the epidemiology of anti-neutrophil cytoplasm antibody-associated renal vasculitis and the role of histologic chronicity in predicting renal outcomes,"A Kronbichler, DRW Jayne",Nephrology Dialysis Transplantation,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=909404029583157544,1,2019
Nasal carriage of ,"A Kronbichler, B Blane, MA Holmes, J Wagner, J Parkhill, SJ Peacock, ...","Rheumatology 58 (3), 548-550",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11120474004379411360,1,2018
A retrospective study comparing the phenotype and outcomes of patients with polyarteritis nodosa between UK and Turkish cohorts,"O Karadag, A Erden, Y Bilginer, S Gopaluni, A Sari, B Armagan, I Ertenli, ...","Rheumatology international 38 (10), 1833-1840",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1324600365307026847,1,2018
A Randomized Phase 3 Trial Evaluating the Safety and Efficacy of Avacopan in Patients with New or Relapsing Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,"PA Merkel, D Jayne, TJ Schall, P Bekker, J Hillson",ARTHRITIS & RHEUMATOLOGY 70,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14411701715910642886,1,2018
"A phase III randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of abatacept or placebo on standard of care in patients with active class III …","MA Dooley, GB Appel, R Furie, D Wofsy, T Takeuchi, A Malvar, A Doria, ...",ARTHRITIS & RHEUMATOLOGY 70,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12809897632862563472,1,2018
Lupus Nephritis,"S Wadhwani, D Jayne, BH Rovin","SPEC-Comprehensive Clinical Nephrology 15, 306",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1766093731317420606,1,2018
Comment on: The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: reply,"C Gordon, MB Amissah-Arthur, M Gayed, S Brown, IN Bruce, D D’Cruz, ...","Rheumatology 57 (8), 1502-1503",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17931862827742351499,1,2018
Highlights of the 2nd EUVAS Vasculitis Course,"G Emmi, C Salvarani, D Prisco, DRW Jayne, A Vaglio",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15523529225333418433,1,2018
New Use for an Old Drug: Hydroxychloroquine for the Treatment of ANCA Associated Vasculitis,"A Casian, R Jones, R Cader, AD Salama, S Sangle, D Jayne, DP D'Cruz",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18227933043005131095,1,2017
THU0333 Are the demographic and clinical features of polyarteritis nodosa similar between the uk and turkey?,"O Karadag, A Erden, ED Batu, S Gopaluni, A Sari, B Armagan, I Ertenli, ...","Annals of the Rheumatic Diseases 76 (Suppl 2), 329-329",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17906694842897735678,1,2017
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in …,"EM McCarthy, E Sutton, S Nesbit, B Parker, D Jayne, B Griffiths, ...","Rheumatology 56 (6), 1041-1043",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15969243301866613063,1,2017
SP119 ADULT-ONSET IGA VASCULITIS TREATED WITH RITUXIMAB. A CASE SERIES,"F Maritati, R Fenoglio, E Pillebout, G Emmi, ML Urban, AJ Mohammad, ...","Nephrology Dialysis Transplantation 32 (suppl_3), iii145-iii145",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7439611467316155573,1,2017
Response to:‘Renal biopsies should be performed whenever treatment strategies depend on renal involvement’by Chemouny et al,"M Yates, DR Jayne, C Mukhtyar","Annals of the rheumatic diseases, annrheumdis-2016-210962",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9618662181505871109,1,2017
Progressive multifocal leucoencephalopathy with Behçet's disease: an insight into pathophysiology.,"S Agarwal, J Patrick, JL Jones, RM Smith, AJ Coles, DR Jayne",Oxford University Press,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7576982917917882432,1,2017
An unusual finding in a 57-year-old woman with new onset hypertension and a diastolic murmur,"JM Tarkin, JHF Rudd, DR Jayne, RA Rusk, D Gopalan","Heart 102 (21), 1762-1762",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16003006068290923709,1,2016
ISN Nexus 2016 Symposia: translational immunology in kidney disease—the berlin roadmap,"HJ Anders, B Rovin, D Jayne, P Brunetta, R Coppo, A Davidson, ...","Kidney international reports 1 (4), 327-339",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12897494103491174050,1,2016
Successful outcome using bortezomib in adult refractory IgA vasculitis: a case report,"E Van de Perre, RM Smith, V Bardsley, C Crawley, LC Willcocks, ...","Rheumatology 55 (11), 2089-2091",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14866896180349738114,1,2016
MO040ASSOCIATION OF A ,"F Alberici, R Smith, M Fonseca, L Willcocks, R Jones, J Holle, ...","Nephrology Dialysis Transplantation 31 (suppl_1), i45-i46",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7227341507762449857,1,2016
The BSR and BHPR guideline for the management of systemic lupus erythematosus in adults,"C Gordon, MB Amissah-Arthur, M Gayed, S Brown, IN Bruce, D D'Cruz, ...","Full guideline revised 13, 05-16",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12093634276498595963,1,2016
A case of de novo diagnosis anca-negative pauci-immune necrotising glomerulonephritis in pregnancy,"C Conduit, S Yew, M Jose, D Jayne, G Kirkland","Nephrology, 270, Vol 21 (Supp. 2), 289",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6510540516186296489,1,2016
Long-term Outcomes of Takayasu's Arteritis Patients with Renal Artery Involvement,"C Baldwin, A Mohammad, D Jayne","JOURNAL OF RHEUMATOLOGY 42 (7), 1282-1282","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17719635534394162067,8043782299212855378",1,2015
Biologic treatment in glomerular disease,"D Jayne, V Tesar","Nephron Clinical Practice 128 (3-4), 203-204",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7979269111224525147,1,2014
UNITED KINGDOM & IRELAND VASCULITIS REGISTRY (UKIVAS)–CROSS-SECTIONAL DATA ON THE FIRST 654 PATIENTS,"J Sznajd, AD Salama, D Jayne, A Chaudhry, M Robson, J Rosa, J Barrett, ...",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4250807633423102454,1,2014
OP0124 Contextualising quality of life in ANCA associated vasculitis (AAV),"N Basu, A McClean, R Luqmani, L Harper, O Flossmann, D Jayne, M Little, ...","Annals of the Rheumatic Diseases 71 (Suppl 3), 95-95",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14639379303213955399,1,2013
Oral Abstracts 1: Connective Tissue Disease O1. Long-Term Outcomes of Children Born to Mothers with SLE,"M Gayed, F Leone, V Toescu, I Bruce, I Giles, LS Teh, N McHugh, ...","Rheumatology 52 (suppl_1), i26-i32",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17237583901715815441,1,2013
A risk score for predicting short-term incidence of death or relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis,"C Maldini, M Resche-Rigon, D Jayne, K Westman, A Mahr",Press Med 42 (4),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16986130285445924404,1,2013
Characteristics and outcome of patients with granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis on renal replacement therapy–Data from the ERA-EDTA registry,"Z Hruskova, VS Stel, DR Jayne, V Tesar, KJ Jager, OBOT National","La Presse Medicale 42 (4), 675",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15902867423330211856,1,2013
Long term follow up of patients who received repeat dose rituximab as maintenance therapy for ANCA associated vasculitis (AAV),"R Smith, F Alberici, R Jones, D Jayne","La Presse Médicale 42 (4P2), 775-776",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7115263271229444255,1,2013
"Developing Guideline for Polymyalgia Rheumatica: Prioritisation of Outcome Measures-Perspective of Patients, General Practitioners and Rheumatologists","Y Singh, C Dejaco, S Mackie, D Ching, A Bachta, A Maharaj, A Wagner, ...","Arthritis and rheumatism 65, S703-S704",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1929016460130200118,1,2013
Alveolar haemorrhage in ANCA-AAV: an analysis of EUVAS trials,"A Casian, M Walsh, A Berden, D Jayne",Clinical and Experimental Immunology 164,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=548869386595666138,1,2011
ALEMTUZUMAB (CAMPATH-1H) AS REMISSION INDUCTION THERAPY IN BEHCET'S DISEASE,"R Smith, YW Chow, D Jayne","CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 28 (4), S129-S130",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3004272171397242979,1,2010
A CD8 T-cell memory transcription signature predicts prognosis in autoimmune disease,"E Mckinney, P Lyons, E Carr, J Hollis, D Jayne, L Willcocks, M Koukoulaki, ...",Apmis 117,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11166561487230842277,1,2009
The vasculitic diseases.,D Jayne,"Best practice & research. Clinical rheumatology 23 (3), 305",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13943526918481816035,1,2009
Bimodal mortality risk in Wegener's granulomatosis,"RA Luqmani, C Edwards, D Culliford, J Maskell, D Jayne, N Arden",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12025578089745032905,1,2009
The association between relapses of ANCA-associated vasculitis and the composite endpoint of end-stage renal disease or death,"M Walsh, O Flossman, A Berden, K Westman, B Manns, D Jayne","APMIS1988-01-01+ 01: 00 117, 143-144",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17162266558247663252,1,2009
More on Anti-Glomerular Basement Membrane Disease after Alemtuzumab Reply,"MR Clatworthy, EF Wallin, DR Jayne",NEW ENGLAND JOURNAL OF MEDICINE 359 (23),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15450110016186707618,1,2008
Cardiovascular outcomes in ANCA associated Vasculitis,"C Mukhtyar, O Flossmann, D Brown, K Westman, D Jayne, R Luqmani",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10261652255703888496,1,2008
"Anaemia, weight loss, and round shadows in the lungs","AS Thakor, TF Hiemstra, DRW Jayne","The Lancet 371 (9606), 88",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3507078870523155454,1,2008
ANCA-Associated Vasculitis: Clinical Features and Treatment,D Jayne,"Handbook of Systemic Autoimmune Diseases 7, 139-157",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14689330270047675662,1,2007
"Rituximab en el tratamiento de la vasculitis asociada con anticuerpos frente a citoplasma de neutrófilos y el lupus eritematoso sistémico: Pasado, presente y futuro","M Walsh, D Jayne","Kidney Int (Edición española) 3, 251-6",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9569170362456112874,1,2007
Assessment of damage in vasculitis: Expert ranking of items of damage,"P Seo, DRW Jayne, RA Luqmani, PA Merkel",CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 25 (1),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7041246826085510745,1,2007
"Factors influencing remission, relapse, renal failure and mortality in patients with systemic vasculitis","R Luqmani, C Mukhtyar, O Flossmann, B Hellmich, DRW Jayne",CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 25 (1),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3294398886238050520,1,2007
Long-term follow up of EUVAS studies,"O Flossmann, L Harper, DRW Jayne, R Luqmani, K Westman",CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 25 (1),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1507403703523084592,1,2007
Predictors of outcome in renal vasculitis.,D Jayne,"Nephrology (Carlton, Vic.) 9 (5), 254",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5961179310253038683,1,2004
CARDIOVASCULAR AND CEREBROVASCULAR DISEASE INCIDENCE AND RISK FACTORS IN ANCA-ASSOCIATED PRIMARY SYSTEMIC VASCULITIS (AASV),"EM Salisbury, JS McLaren, DRW Jayne, RA Luqmani",Rheumatology 43,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8133264287238387197,1,2004
"A prospective, open label trial of B-cell depletion with rituximab in refractory systemic lupus erythematosus.","KGC Smith, DRW Jayne","JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 14, 380A-380A",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1961515250028502183,1,2003
Cardiovascular disease incidence and risk factors in ANCA-associated primary systemic vasculitis (AASV),"EM Salisbury, JS McLaren, DRW Jayne, RA Luqmani",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11317442099705260707,1,2003
Clinical trials in nephrology,D Jayne,"BRITISH JOURNAL OF RENAL MEDICINE 8 (1), 23-27",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12153826407630273602,1,2003
Prospective study of remission induction by mycophenolate mofetil in lupus nephritis.,"C Gordon, J Cross, D Adu, D Jayne",Arthritis & Rheumatism 44 (9),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9779599712667484987,1,2001
Intravenous immunoglobulin as immuno-modifying treatment,D Jayne,"Disease-modifying Therapy in Vasculitides, 81-111",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14063305927000765010,1,2001
Current trends in therapy for primary systemic vasculitis,D JAYNE,"Nephrology 3, s785-s787",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2593007282631300176,1,1997
Bactericidal/permeability-increasing protein (BPI): A novel target antigen for P-ANCA in inflammatory bowel disease,"M Hamilton, MH Zhao, P Chapman, D Jayne, R Pounder, AJ Wakefield, ...","Gastroenterology 108 (4), A830",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8256771973809054351,1,1995
Introduction to a collection of invited papers on systemic vasculitis,"DRW Jayne, CM Lockwood","Journal of Autoimmunity 6 (2), 169",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8890989903787701846,1,1993
IGM ANTINEUTROPHIL CYTOPLASM ANTIBODIES (ANCA) ARE ASSOCIATED WITH PULMONARY HEMORRHAGE IN IGG ANCA POSITIVE SYSTEMIC VASCULITIS,"VLM Esnault, AA Brownlee, MT Keogan, DRW Jayne, CM Lockwood","CLINICAL RESEARCH 39 (2), A174-A174",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16493044083443927469,1,1991
The specificity of anti-neutrophil cytoplasm autoantibodies (ANCA) in systemic vasculitides,"CM Lockwood, KN Lai, A Brownlee, D Jayne","KIDNEY INTERNATIONAL 37 (1), 443-443",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10805976026703894743,1,1990
Prognosis and Outcomes of ANCA-Associated Vasculitis,D Jayne,"Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis, 293-311",,0,2020
La granulomatose éosinophilique avec polyangéite (Churg-Strauss) avec positivité des ANCA-PR3 existe-t-elle réellement?,"M Papo, RA Sinico, V Teixeira, ML Urban, J Mahrhold, S Monti, ...","La Revue de Médecine Interne 40, A58-A59",,0,2019
The composition and functional protein subsystems of the human nasal microbiome in granulomatosis with polyangiitis: a pilot study,"J Wagner, EM Harrison, MM Del Pero, B Blane, G Mayer, J Leierer, ...","Microbiome 7 (1), 1-17",,0,2019
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status,"PA Lyons, JE Peters, F Alberici, J Liley, RMR Coulson, W Astle, C Baldini, ...","Nature communications 10 (1), 1-13",,0,2019
Case reports of immunosuppression therapy for anti-insulin receptor and anti-insulin antibodies in patients attending the national severe insulin resistance service,"CJ Liu, C Adams, D Church, C Flanagan, L Gaff, D Jayne, A Melvin, ...",Society for Endocrinology BES 2019 65,,0,2019
Complement inhibition in ANCA vasculitis,D Jayne,"Nephrologie & therapeutique 15 (6), 409-412",,0,2019
New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group,"C Marvisi, RA Sinico, C Salvarani, D Jayne, D Prisco, B Terrier, G Emmi, ...","Internal and emergency medicine 14 (8), 1193-1197",,0,2019
Coincident relapsing polychondritis and IgG4-related disease: a diagnostic challenge.,"A Le Goueff, F Vandergheynst, D Jayne",Towarzystwo Internistow Polskich/Polish Society of Internal Medicine,,0,2019
Integrated safety profile of atacicept: an analysis of pooled data from the atacicept clinical trial programme,"C Gordon, R Bassi, P Chang, A Kao, D Jayne, D Wofsy, ...","Rheumatology advances in practice 3 (2), rkz021",,0,2019
Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis,"ME McClure, J Wason, S Gopaluni, J Tieu, RM Smith, DR Jayne, ...","JCR: Journal of Clinical Rheumatology 25 (5), 217-223",,0,2019
Iatrogenic antibody deficiency from B-cell targeted therapies in autoimmune rheumatic diseases,"S Wijetilleka, D Jayne, C Mukhtyar, MY Karim","Lupus Science & Medicine 6 (1), e000337",,0,2019
The Longitudinal Course of Fatigue in Anca Associated Vasculitis,"L O’Malley, K Druce, D Chanouzas, M Morgan, R Jones, D Jayne, N Basu, ...","The Journal of rheumatology, jrheum. 190113",,0,2019
Keratinocyte growth factor impairs human thymic recovery from lymphopenia,"AJ Coles, L Azzopardi, O Kousin-Ezewu, HK Mullay, SAJ Thompson, ...",JCI insight 4 (12),,0,2019
Response to:‘Mycophenolate mofetil: a step forward in the induction treatment of ANCA-associated vasculitis? Comment on the article by Jones et al’by Vandergheynst et al,"RB Jones, TF Hiemstra, M Walsh, D Jayne, L Harper","Annals of the Rheumatic Diseases, annrheumdis-2019-215658",,0,2019
SLOWLY PROGRESSIVE ANCA-ASSOCIATED GLOMERULONEPHRITIS: A MULTICENTRE STUDY,"G Trivioli, S Gopaluni, ML Urban, D Gianfreda, MA Cassia, PG Vercelloni, ...","NEPHROLOGY DIALYSIS TRANSPLANTATION 34, 99-99",,0,2019
CARDIOVASCULAR DISEASE IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,"A Egan, M Bond, D Jayne","NEPHROLOGY DIALYSIS TRANSPLANTATION 34, 401-401",,0,2019
SP162 RENAL INVOLVEMENT IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,"A Egan, T Bada, D Jayne","Nephrology Dialysis Transplantation 34 (Supplement_1), gfz103. SP162",,0,2019
FP165 Slowly progressive anca-associated glomerulonephritis: a multicentre study,"G Trivioli, S Gopaluni, ML Urban, D Gianfreda, MA Cassia, PG Vercelloni, ...","Nephrology Dialysis Transplantation 34 (Supplement_1), gfz106. FP165",,0,2019
SP117 CARDIOVASCULAR DISEASE IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,"A Egan, M Bond, D Jayne","Nephrology Dialysis Transplantation 34 (Supplement_1), gfz103. SP117",,0,2019
FP216 Renal involvement in EGPA: a multicentre retrospective study of 63 cases,"A Karras, D Jayne, V Teixeira, RA Sinico, X Belenfant, CA Durey","Nephrology Dialysis Transplantation 34 (Supplement_1), gfz106. FP216",,0,2019
FRI0194 INTEGRATED SAFETY PROFILE OF ATACICEPT FROM ALL CLINICAL STUDIES TO DATE,"C Gordon, R Bassi, P Chang, A Kao, D Jayne, D Wofsy, V Ona, ...","Annals of the Rheumatic Diseases 78 (Suppl 2), 775-775",,0,2019
SAT0221 OFF-LABEL USE OF BIOLOGICAL THERAPIES IN RELAPSING AND/OR REFRACTORY POLYARTERITIS NODOSA,"A Canzian, O Karadag, A Contis, F Maurier, S Sartorelli, L Denis, ...","Annals of the Rheumatic Diseases 78 (Suppl 2), 1186-1187",,0,2019
SP0182 TREATMENT OF AAV,D Jayne,"Annals of the Rheumatic Diseases 78 (Suppl 2), 55-55",,0,2019
SAT0667 TREATMENT RESPONSE CRITERIA FOR ANCA-ASSOCIATED VASCULITIS: RESULTS OF A SCOPING REVIEW,"S Monti, KA Quinn, R Christensen, A Mahr, C Pagnoux, C Langford, ...","Annals of the Rheumatic Diseases 78 (Suppl 2), 1432-1433",,0,2019
FRI0287 EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS,"M Papo, RA Sinico, V Teixeira, ML Urban, J Mahrhold, S Monti, ...","Annals of the Rheumatic Diseases 78 (Suppl 2), 824-824",,0,2019
SAT0239 PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG–STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS,"M Papo, RA Sinico, V Teixeira, ML Urban, J Mahrhold, S Monti, ...","Annals of the Rheumatic Diseases 78 (Suppl 2), 1196-1196",,0,2019
FRI0192 A SYSTEMATIC LITERATURE REVIEW TO INFORM THE 2019 UPDATE OF THE EULAR RECOMMENDATIONS FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS,"A Fanouriakis, M Kostopoulou, A Alunno, M Aringer, I Bajema, JN Boletis, ...","Annals of the Rheumatic Diseases 78 (Suppl 2), 773-774",,0,2019
242 Baseline characteristics of patients with lupus nephritis requiring rituximab therapy: results from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR),"S Collinson, B Parker, EM McCarthy, E Sutton, D Jayne, B Griffiths, ...","Rheumatology 58 (Supplement_3), kez107. 058",,0,2019
210 Integrated safety profile of atacicept from all clinical studies to date,"C Gordon, R Bassi, P Chang, AH Kao, D Jayne, D Wofsy, V Ona, ...","Lupus Science & Medicine 6 (Suppl 1), A157-A158",,0,2019
Re:‘ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies’ by Mikulska et al.,"S Wijetilleka, D Jayne, C Mukhtyar, MY Karim","Clinical Microbiology and Infection 25 (4), 531-532",,0,2019
THE EFFECT OF REDUCED-DOSE ORAL GLUCOCORTICOIDS DURING INDUCTION OF REMISSION INDUCTION IN SEVERE ANCA-ASSOCIATED VASCULITIS,"M Walsh, P Merkel, D Jayne",RHEUMATOLOGY 58,,0,2019
255. RENAL INVOLVEMENT IN EGPA: A MULTICENTRE RETROSPECTIVE STUDY OF 63 CASES,"CA Durel, R Sinico, V Teixeira, D Jayne, X Belenfant, A Karras","Rheumatology 58 (Supplement_2), kez062. 029",,0,2019
"ALEMTUZUMAB FOR THE TREATMENT OF REFRACTORY BEHCET'S DISEASE: A SUBGROUP ANALYSIS FROM A RANDOMIZED, PROSPECTIVE, OPEN LABEL, DOSE RANGING CLINICAL TRIAL (NCT01405807). A TRIAL …","M Prasinou, R Smith, S Gopaluni, D Jayne","RHEUMATOLOGY 58, 150-150",,0,2019
RENAL INVOLVEMENT IN EGPA: A MULTICENTRE RETROSPECTIVE STUDY OF 63 CASES,"CA Durel, R Sinico, V Teixeira, D Jayne, X Belenfant, A Karras","RHEUMATOLOGY 58, 113-113",,0,2019
INCIDENCE AND PREDICTORS OF SEVERE INFECTIONS IN ANCA-ASSOCIATED VASCULITIS IN A POPULATION-BASED COHORT-PRELIMINARY RESULTS,"J Rathmann, D Jayne, G Jonsso, M Segelmark, A Mohammad","RHEUMATOLOGY 58, 69-69",,0,2019
"CHARACTERISTICS, OUTCOMES AND PROGNOSTIC FACTORS OF PATIENTS WITH ACUTE MANIFESTATION OF SMALL VESSEL VASCULITIS ADMITTED TO INTENSIVE CARE: AN 18-YEAR SINGLE-CENTRE EXPERIENCE","Y Xu, S Gopaluni, J Varley, L Willcocks, D Jayne, R Jones","RHEUMATOLOGY 58, 110-110",,0,2019
THE COMPOSITION OF THE HUMAN NASAL MICROBIOME IN GRANULOMATOSIS WITH POLYANGIITIS: A PILOT STUDY,"A Kronbichler, J Wagner, E Harrison, MM Del Pero, B Blane, G Mayer, ...","RHEUMATOLOGY 58, 77-77",,0,2019
"A RANDOMISED, DOUBLE-BLIND, CONTROLLED, MECHANISTIC STUDY OF RITUXIMAB AND BELIMUMAB COMBINATION THERAPY IN PR3 ANCA-ASSOCIATED VASCULITIS (COMBIVAS): STUDY PROTOCOL","M McClure, S Gopaluni, J Wason, AN Rosen, R Henderson, A Salama, ...","RHEUMATOLOGY 58, 144-144",,0,2019
GENETIC EVIDENCE OF EOSINOPHIL NUMBER UNDERPINNING PR3-AAV AND PLAUSIBLE HOST GENETIC PREDISPOSITION TO MICROBIAL DRIVERS OF DISEASE,"L Wong, F Mescia, F Alberici, MJ Ball, B Baslund, P Brenchley, ...","RHEUMATOLOGY 58, 80-81",,0,2019
PR3-ANCA STATUS FOLLOWING RITUXIMAB: A USEFUL BIOMARKER FOR RELAPSE PREDICTION IN ANCA-ASSOCIATED VASCULITIS,"M McClure, J Wason, S Gopaluni, J Tieu, R Smith, D Jayne, R Jones","RHEUMATOLOGY 58, 12-12",,0,2019
326. A randomized phase 3 trial evaluating the safety and efficacy of avacopan in patients with new or relapsing ANCA-associated vasculitis,"P Merkel, D Jayne, M Harigai, T Schall, P Bekker, A Potarca, J Hillson","Rheumatology 58 (Supplement_2), kez063. 050",,0,2019
354. Efficacy of eosinophilic granulomatosis with polyangiitis treatments according to the type of manifestations based on analysis of 636 patients,"M Papo, A Sinico, V Teixeira, ML Urban, J Mahrhold, G Cassone, ...","Rheumatology 58 (Supplement_2), kez063. 078",,0,2019
176. The composition of the human nasal microbiome in granulomatosis with polyangiitis: a pilot study,"A Kronbichler, J Wagner, E Harrison, MMD Pero, B Blane, G Mayer, ...","Rheumatology 58 (Supplement_2), kez060. 003",,0,2019
"322. A randomised, double-blind, controlled, mechanistic study of rituximab and belimumab combination therapy in PR3 ANCA-associated vasculitis (combivas): study protocol","M McClure, S Gopaluni, J Wason, AN Rosen, R Henderson, A Salama, ...","Rheumatology 58 (Supplement_2), kez063. 046",,0,2019
158. Incidence and predictors of severe infections in ANCA-associated vasculitis in a population-based cohort–preliminary results,"J Rathmann, D Jayne, G Jönsson, M Segelmark, A Mohammad","Rheumatology 58 (Supplement_2), kez059. 035",,0,2019
030. Tolerability and Cell Yield from Nasal Biopsies Obtained in the Outpatient Setting,"M McClure, L Truman, MMD Pero, P Lyons, D Jayne, R Jones","Rheumatology 58 (Supplement_2), kez057. 029",,0,2019
"335. Alemtuzumab for the treatment of refractory behçet’s disease: a subgroup analysis from a randomized, prospective, open label, dose ranging clinical trial (NCT01405807). a …","M Prasinou, R Smith, S Gopaluni, D Jayne","Rheumatology 58 (Supplement_2), kez063. 059",,0,2019
117. Prediction of Long-Term Evolutionary Profiles in Eosinophilic Granulomatosis with Polyangiitis (Churg–Strauss) Based on Baseline and Follow-Up Characteristics,"M Papo, R Sinico, V Teixeira, ML Urban, J Mahrhold, G Cassone, ...","Rheumatology 58 (Supplement_2), kez058. 057",,0,2019
239. Risk factors for the development of chronic kidney disease in adults with iga vasculitis,"B Sanchez, A Egan, D Jayne, L Willcocks, R Jones","Rheumatology 58 (Supplement_2), kez062. 013",,0,2019
255. Renal involvement in EGPA: a multicentre retrospective study of 63 cases,"CA Durel, R Sinico, V Teixeira, D Jayne, X Belenfant, A Karras","Rheumatology 58 (Supplement_2), kez062. 029",,0,2019
185. Genetic evidence of eosinophil number underpinning PR3-AAV and plausible host genetic predisposition to microbial drivers of disease,"L Wong, F Mescia, F Alberici, MJ Ball, B Baslund, P Brenchley, ...","Rheumatology 58 (Supplement_2), kez060. 012",,0,2019
"247. Characteristics, outcomes and prognostic factors of patients with acute manifestation of small vessel vasculitis admitted to intensive care: an 18-year single-centre …","Y Xu, S Gopaluni, J Varley, L Willcocks, D Jayne, R Jones","Rheumatology 58 (Supplement_2), kez062. 021",,0,2019
153. The 10-year long-term follow-up of patients with ANCA-associated vasculitis included in european vasculitis society randomised clinical trials since 1995: a survival analysis,"L Moi, M Faurschou, T Hauser, I Bajema, R Luqmani, A Mahr, D Jayne, ...","Rheumatology 58 (Supplement_2), kez059. 030",,0,2019
"261. Assessment of radiologic damage in large-vessel vasculitis (combined arteritis damage score, cards): a validation study","D Nakagomi, K Kobayashi, S Furuta, K Harama, S Hanai, T Kanzaki, ...","Rheumatology 58 (Supplement_2), kez062. 035",,0,2019
361. The effect of reduced-dose oral glucocorticoids during induction of remission induction in severe ANCA-associated vasculitis,"M Walsh, P Merkel, D Jayne, PEXIVAS Investigators","Rheumatology 58 (Supplement_2), kez063. 085",,0,2019
029. PR3-ANCA Status Following Rituximab: A Useful Biomarker for Relapse Prediction in Anca-Associated Vasculitis,"M McClure, J Wason, S Gopaluni, J Tieu, R Smith, D Jayne, R Jones","Rheumatology 58 (Supplement_2), kez057. 028",,0,2019
302. Alemtuzumab for relapsing and refractory primary systemic vasculitis–a trial of efficacy and safety (aleviate): a randomised open-label phase II clinical trial,"S Gopaluni, D Goymer, M McClure, H Cahill, E Broadhurst, R Smith, ...","Rheumatology 58 (Supplement_2), kez063. 026",,0,2019
159. Infections are associated with increased risk of MPO-but not PR3-ANCA-associated vasculitis-a population-based case-control study from southern sweden,"J Rathmann, P Stamatis, D Jayne, M Segelmark, G Jönsson, ...","Rheumatology 58 (Supplement_2), kez059. 036",,0,2019
330. Treatment response criteria for ANCA-associated vasculitis: results of a scoping review,"S Monti, K Quinn, R Christensen, A Mahr, C Pagnoux, C Langford, ...","Rheumatology 58 (Supplement_2), kez063. 054",,0,2019
013. Percutaneous Lymph Node Biopsy to Explore Immune Dysregulation in Vasculitis: A Pilot Project,"S Gopaluni, J Tieu, M McClure, P Moyle, D Jayne","Rheumatology 58 (Supplement_2), kez057. 012",,0,2019
Visual loss in giant cell arteritis 3 weeks after steroid initiation,"A Le Goueff, J Peters, L Willcocks, D Jayne","BMJ Case Reports CP 12 (3), e228251",,0,2019
295. Cardiovascular disease in eosinophilic granulomatosis with polyangiitis,"A Egan, M Bond, D Jayne","Rheumatology 58 (Supplement_2), kez063. 019",,0,2019
297. Renal involvement in eosinophilic granulomatosis with polyangiitis,"A Egan, T Bada, D Jayne","Rheumatology 58 (Supplement_2), kez063. 021",,0,2019
356. Rituximab associated hypogammaglobulinaemia in autoimmune disease: long term outcomes,"J Tieu, S Gopaluni, M McClure, R Smith, D Jayne","Rheumatology 58 (Supplement_2), kez063. 080",,0,2019
Response to:‘Prevention of infections in patients with antineutrophil cytoplasm antibody-associated vasculitis: potential role of hydroxychloroquine’by Novikov et al,"A Kronbichler, D Jayne","Annals of the rheumatic diseases, annrheumdis-2018-214735",,0,2019
Comment on: A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody–associated vasculitis: reply,"R Pepper, D Jayne, M Little, C Pusey, AD Salama","Rheumatology 58 (4), 738-739",,0,2019
Integrated safety profile of atacicept,"C Gordon, R Bassi, A Kao, D Jayne, D Wofsy, P Fleuranceau-Morel",,,0,2019
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status,"K Smith, P Lyons, J Peters, F Alberici, J Liley, R Coulson, W Astle, ...",,,0,2019
Effect of Disease Activity at Three and Six Months After Diagnosis on Long-Term Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.,"S Gopaluni, O Flossmann, MA Little, P O'Hara, P Bekker, D Jayne",Wiley-Blackwell,,0,2019
Outcome of participants with nephrotic syndrome in combined clinical trials of lupus nephritis,"LMG Mendez, MD Cascino, TR Katsumoto, P Brakeman, P Brunetta, ...","Lupus science & medicine 6 (1), e000308",,0,2019
"B cell therapy in ANCA-associated vasculitis: current and emerging treatment options (vol 14, pg 580, 2018)","M McClure, S Gopaluni, D Jayne, R Jones","NATURE REVIEWS RHEUMATOLOGY 14 (12), 741-741",,0,2018
Caractéristiques de l’atteinte rénale au cours de la granulomatose éosinophilique avec polyangéite: étude rétrospective multicentrique portant sur 63 patients avec histologie …,"CA Durel, RA Sinico, V Teixeira, D Jayne, X Belenfant, S Marchand-Adam, ...","La Revue de Médecine Interne 39, A27-A28",,0,2018
Trimethoprim-sulfamethoxazole prophylaxis reduces the rate of severe infection complications in patients with ANCA-associated vasculitis and rituximab therapy,"P Gauckler, J Kerschbaum, D Jayne, A Kronbichler","WIENER KLINISCHE WOCHENSCHRIFT 130, 272-273",,0,2018
Venous Thromboembolism in ANCA Associated Vasculitis. a Population-Based Cohort Study from Southern Sweden,"M Liapi, D Jayne, M Segelmark, A Mohammad",ARTHRITIS & RHEUMATOLOGY 70,,0,2018
Clinical Features and Outcome of Patients with Polyarteritis Nodosa-a Global Collaborative Study,"O Karadag, S Furuta, A Hocevar, U Gazel, S Gopaluni, B Armagan, ...",ARTHRITIS & RHEUMATOLOGY 70,,0,2018
Integrated Safety Profile of Atacicept from All Clinical Studies to Date,"C Gordon, R Bassi, P Chang, AH Kao, D Jayne, D Wofsy, V Ona, ...",ARTHRITIS & RHEUMATOLOGY 70,,0,2018
A 24 Month Analysis of Rituximab Safety and Efficacy in Eosinophilic Granulomatosis with Polyangiitis,"V Teixeira, A Mohammad, D Jayne, V Teixeira, A Mohammad, D Jayne",ARTHRITIS & RHEUMATOLOGY 70,,0,2018
Long-term outcomes of patients with Takayasu arteritis and renal artery involvement: a cohort study,"C Baldwin, AJ Mohammad, C Cousins, S Carette, C Pagnoux, D Jayne","Rheumatology Advances in Practice 2 (2), rky026",,0,2018
"Abatacept does not improve remission rate in lupus nephritis, but leads to faster falls in proteinuria",D Jayne,"BRITISH JOURNAL OF HOSPITAL MEDICINE 79 (7), 370-370",,0,2018
AB0692 Belimumab in combination with azathioprine for remission maintenance in granulomatosis with polyangiitis and microscopic polyangiitis: effect on biomarkers,"D Jayne, D Blockmans, R Luqmani, B Ji, Y Green, L Hall, D Roth, ...","Annals of the Rheumatic Diseases 77 (Suppl 2), 1488-1488",,0,2018
ADVERSE EVENTS WITH GLUCOCORTICOID STANDARD OF CARE VERSUS AVACOPAN IN ANCA-ASSOCIATED VASCULITIS: OBSERVATIONS FROM THE CLEAR TRIAL,"D Jayne, A Potarca, T Schall, J Hilson, P Becker",NEPHROLOGY DIALYSIS TRANSPLANTATION 33,,0,2018
SaO020 RITUXIMAB AS MAINTENANCE THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS,"F Alberici, M Cassia, R Jones, G Casazza, ML Urban, G Emmi, G Moroni, ...","Nephrology Dialysis Transplantation 33 (suppl_1), i323-i323",,0,2018
FP155 PREDICTORS OF RENAL INVOLVEMENT IN ANCA ASSOCIATED VASCULITIS,"A Kronbichler, JI Shin, K Lee, D Nakagomi, L Quintana, M Busch, ...","Nephrology Dialysis Transplantation 33 (suppl_1), i81-i82",,0,2018
Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis,"M Weiner, R Bjørneklett, Z Hrušková, B Mackinnon, CJ Poulton, ...","Nephrology Dialysis Transplantation 34 (2), 301-308",,0,2018
Ahmed Saleh and Mohammad al-Shatouri,"SP McAdoo, N Medjeral-Thomas, S Gopaluni, A Tanna, N Mansfield, ...","Nephrol Dial Transplant 33, 899",,0,2018
Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria,"D Khanna, D Daikh, R Cervera, N Costedoat-Chalumeau, D Gladman, ...",,,0,2018
Present and future of ANCA-associated vasculitis,D Jayne,"REVUE DE MEDECINE INTERNE 38, A10-A12",,0,2017
Requirement and Response Rates of Biologic Agents in Polyarteritis Nodosa (PAN),"O Karadag, B Armagan, A Erden, S Gopaluni, A Sari, S Kiraz, D Jayne",ARTHRITIS & RHEUMATOLOGY 69,,0,2017
Introduction: Translational Immunology in Kidney Disease,"HJ Anders, D Jayne, B Rovin","Seminars in nephrology 37 (5), 417",,0,2017
"OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial","ME Wechsler, P Akuthota, D Jayne, P Khoury, A Klion, C Langford, ...","Annals of the Rheumatic Diseases 76 (Suppl 2), 107-107",,0,2017
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.,"E Wechsler Michael, P Akuthota, D Jayne, P Khoury, K D Amy, ...",,,0,2017
The United Kingdom and Ireland Vasculitis Registry: Cross-sectional data on the first 3195 patients with a focus on anti-neutrophil cytoplasm–associated vasculitis and giant …,"RA Luqmani, A Craven, J Sznajd, N Basu, J Barrett, D Jayne, P Lanyon, ...",Oxford University Press 56 (Suppl 2),,0,2017
O17. The UNITED KIGDOM AND Ireland Vasculitis Registry: Cross-sectional data on the first 3195 patients with a focus on anti-neutrophil cytoplasm–associated vasculitis and …,"RA Luqmani, A Craven, J Sznajd, N Basu, J Barrett, D Jayne, P Lanyon, ...",Rheumatology 56 (suppl_2),,0,2017
THE UNITED KIGDOM AND IRELAND VASCULITIS REGISTRY: CROSS-SECTIONAL DATA ON THE FIRST 3195 PATIENTS WITH A FOCUS ON ANTI-NEUTROPHIL CYTOPLASM-ASSOCIATED VASCULITIS AND GIANT …,"RA Luqmani, A Craven, J Sznajd, N Basu, J Barrett, D Jayne, P Lanyon, ...","RHEUMATOLOGY 56, 34-35",,0,2017
DEMOGRAPHIC CHARACTERISTICS OF JAPANESE PARTICIPANTS IN PEXIVAS AS COMPARED WITH REMIT-JAV,"H Kono, S Uchida, E Muso, T Endo, H Kakita, Y Hamano, T Tsukamoto, ...","RHEUMATOLOGY 56, 150-150",,0,2017
"P2_131 Two International Multiregional Investigator Initiated Clinical Trials on Vasculitis: Collaboration with EUVAS, VCRC and Nationwide Vasculitis Study Groups of Japan","T Ito-Ihara, S Furuta, Y Komagata, E Muso, T Endo, S Uchida, H Kono, ...","Rheumatology 56 (suppl_3), iii149-iii157",,0,2017
P1_1 Clinical features of Takayasu Arteritis from an Inception Cohort: Early disease is characterized by systemic inflammation,"F Alibaz-Oner, HA Uchida, Y Nakaoka, H Yoshifuji, T Sugihara, ...","Rheumatology 56 (suppl_3), iii43-iii52",,0,2017
WS2_1 The UK & Ireland Vasculitis Registry (UKIVAS): Cross-sectional data on the first 2290 Patients with anti-neutrophil cytoplasm (ANCA) associated vasculitis (AAV),"RA Luqmani, A Craven, J Sznajd, N Basu, J Barrett, D Jayne, P Lanyon, ...","Rheumatology 56 (suppl_3), iii20-iii22",,0,2017
P2_118 Central Nervous System involvement in patients with Granulomatosis with Polyangiitis: A single center experience,"G Fragoulis, S Lionaki, A Venetsanopoulou, A Tzioufas, ...","Rheumatology 56 (suppl_3), iii144-iii149",,0,2017
"P2_23 Induction of Cutaneous and Ear, Nose and Throat (ENT) Manifestations in a Mouse Model of MPO-ANCA Granulomatosis with Polyangiitis","MA Alba, X Hong, P Hu, RJ Falk, C Jennette, JD Ooi, JH Jiang, ...","Rheumatology 56 (suppl_3), iii111-iii122",,0,2017
P2_81 MPO-ANCA is a Promising Biomarker for Relapse in Renal Vasculitis; Subgroup Analysis of Nationwide Prospective Cohort Study of ANCA-Associated Vasculitis and Rapidly …,"H Watanabe, K Sada, H Makino, ...","Rheumatology 56 (suppl_3), iii130-iii135",,0,2017
Long-term follow-up of a combined rituximab and low-dose cyclophosphamide regimen for remission induction in renal anca-associated vasculitis,"SP McAdoo, S Gopaluni, N Medjeral-Thomas, A Tanna, M Griffith, J Levy, ...",Oxford University Press (OUP),,0,2017
ONE THIRD OF EGPA PATIENTS HAVE INFLAMMATORY HEART DISEASE,"E Garcia, L Harty, D Jayne","RHEUMATOLOGY 56, 148-148",,0,2017
ASSESSMENT OF CURRENT TREATMENT PRACTICE AND UNMET CLINICAL NEEDS IN ANCA-ASSOCIATED VASCULITIS,"PA Merkel, DR Jayne, R Luqmani, T Shetty, D Close","RHEUMATOLOGY 56, 164-164",,0,2017
SERUM CD23 IS ASSOCIATED WITH NAIVE B CELL REPOPULATION AFTER RITUXIMAB IN ANCA ASSOCIATED VASCULITIS,"L Harty, R Smith, S Gopaluni, M Leandro, G Cambridge, D Jayne",18th International Vasculitis and ANCA Workshop,,0,2017
P2_156 Analysis of the incidence and types of adverse events resulted in the discontinuation of immunosuppressant in patients with antineutrophil cytoplasmic antibody …,"T Murosaki, T Sato, K Nagatani, Y Akiyama, S Minota, J Niles, NB Allen, ...","Rheumatology 56 (suppl_3), iii157-iii160",,0,2017
P2_163 Analyses of responsible genetic factors for systemic vasculitides using recombinant inbred collagen disease model mice,"T Miyazaki, K Noguchi, K Kobayashi, N Suzui, A Hara, N Sasaki, ...","Rheumatology 56 (suppl_3), iii160-iii165",,0,2017
"RITAZAREM: AN INTERNATIONAL, OPEN-LABEL, RANDOMISED CONTROLLED TRIAL COMPARING RITUXIMAB WITH AZATHIOPRINE AS MAINTENANCE THERAPY IN RELAPSING ANCA-ASSOCIATED VASCULITIS","RM Smith, Y Arimura, PA Merkel, DRW Jayne","RHEUMATOLOGY 56, 150-151",,0,2017
P2_115 Factors Influencing First Major Infection Occurrence in Granulomatosis with Polyangiitis (GPA),"LF Flores-Suarez, J Mena Zuniga, AR Villa, N Ruiz, K Takahashi, ...","Rheumatology 56 (suppl_3), iii143-iii144",,0,2017
TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS PREVENTS SEVERE INFECTIONS IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS,"A Kronbichler, J Kerschbaum, S Gopaluni, F Alberici, R Jones, R Smith, ...",RHEUMATOLOGY 56,,0,2017
MICROPARTICLES AS A THERAPEUTIC TARGET FOR PLASMA EXCHANGE IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY ASSOCIATED VASCULITIS,"Y Hong, D Eleftheriou, S Nanthapisal, A Salama, D Jayne, M Little, ...",,,0,2017
PLASMA EXCHANGE AND GLUCOCORTICOID DOSING IN THE TREATMENT OF ANTI-NEUTROPHIL CYTOPLASM ANTIBODY ASSOCIATED VASCULITIS: BASELINE CHARACTERISTICS OF A RANDOMIZED CONTROLLED …,"M Walsh, P Merkel, CA Peh, L Guillevin, S Fujimoto, N Ives, DRW Jayne","RHEUMATOLOGY 56, 149-149",,0,2017
"AGE, GFR, BVAS AND VDI AT 6 MONTHS PREDICT MORTALITY & END STAGE RENAL FAILURE IN ANCA ASSOCIATED VASCULITIS","S Gopaluni, D Jayne","RHEUMATOLOGY 56, 134-134",,0,2017
A Steroid Free Maintenance Regime is an Effective and Safe Treatment Strategy in ANCA Associated Vasculitis And Glomerulonephritis,"RJ Pepper, S Moran, D Kelly, P Gopaluni, D Jayne, S Hamour, A Burns, ...",18th International Vasculitis and ANCA Workshop,,0,2017
"Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial","ME Wechsler, P Akuthota, D Jayne, P Khoury, A Klion, C Langford, ...",,,0,2017
Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis,"M Fernandez Nieto, DR Jayne","NEPHROLOGY DIALYSIS TRANSPLANTATION 31 (10), 1566-1567",,0,2016
High Prevalence of Inflammatory Heart Disease in Eosinophillic Granulomatosis with Polyangiitis (Churg Strauss) Patients,"EG Vives, L Harty, D Jayne",ARTHRITIS & RHEUMATOLOGY 68,,0,2016
Opponent's comments.,"MN Fernandez, DR Jayne","Nephrology, dialysis, transplantation: official publication of the European …",,0,2016
Opponent's comments,"M Fernandez Nieto, DR Jayne","Nephrology Dialysis Transplantation 31 (10), 1566-1567",,0,2016
FRI0378 National Audit of Vasculitis Inpatient Comorbidities and Mortality from 2005-14,"L Harty, S Burns, D Jayne","Annals of the Rheumatic Diseases 75 (Suppl 2), 571-571",,0,2016
OP0053 Eular/ERA-EDTA Recommendations for The Management of Anca-Associated Vasculitis,"M Yates, R Watts, I Bajema, M Cid, B Crestani, T Hauser, B Hellmich, ...","Annals of the Rheumatic Diseases 75 (Suppl 2), 74-74",,0,2016
AB0512 Use of Nominal Group Technique To Facilitate Item Reduction for Sle Classification Criteria Development,"S Johnson, D Khanna, R Cervera, N Costedoat-Chalumeau, DD Gladman, ...","Annals of the Rheumatic Diseases 75 (Suppl 2), 1080-1081",,0,2016
RISK OF VENOUS THROMBOEMBOLIC EVENTS IN ANCA ASSOCIATED VASCULITIS,"A Kronbichler, J Leierer, G Leierer, G Mayer, A Casian, P Hoglund, ...","NEPHROLOGY DIALYSIS TRANSPLANTATION 31, 77-78",,0,2016
IGAVASCULITIS (HENOCH-SCHONLEIN PURPURA): REFRACTORY AND RELAPSING DISEASE COURSE IN THE ADULT POPULATION,"E Van de Perre, RB Jones, DR Jayne","NEPHROLOGY DIALYSIS TRANSPLANTATION 31, 130-130",,0,2016
SP143 EULAR/ERA-EDTA RECOMMENDATIONS FOR THE MANAGEMENT OF ANCA-ASSOCIATED VASCULITIS,"M Yates, R Watts, N Nilüfer, I Bajema, M Little, M Segelmark, V Tesar, ...","Nephrology Dialysis Transplantation 31 (suppl_1), i133-i133",,0,2016
"I70 Development of Evidence-Based Recommendations for Diagnosis, Assessment and Treatment of Lupus","C Gordon, MB Amissah-Arthur, M Gayed, I Bruce, D d'Cruz, B Empson, ...","Rheumatology 55 (suppl_1), i14-i14",,0,2016
Rapid onset of action of orally administered C5aR Inhibitor CCX168 in randomized clinical trial in ANCA-associated vasculitis (CLEAR),"V Tesar, DRW Jayne, A Bruchfeld, L Harper, M Schaier, P Hamilton, ...",ASN Renal Week,,0,2016
Translational Immunology in kidney disease: The Berlin Roadmap,"HJ Anders, B Rovin, D Jayne, P Brunetta, R Coppo",,,0,2016
Infections Observed in Rituximab Treated Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register,"E McCarthy, E Sutton, D Isenberg, A Rahman, B Rhodes, P Hewins, ...","Arthritis & Rheumatology 67, 2174-2175",,0,2015
Opponent's comments,"A Kronbichler, DRW Jayne","Nephrology Dialysis Transplantation 30 (7), 1087-1088",,0,2015
OP0239 Comprehensive Analyses of Lung Abnormalities on Chest Computed Tomography in Patients with Microscopic Polyangiitis before Receiving Immunosuppressive Treatment,"M Yamagata, K Ikeda, K Tsushima, K Iesato, M Abe, T Ito, ...","Annals of the Rheumatic Diseases 74 (Suppl 2), 162-162",,0,2015
Special Issue on Vasculitis: Clinical and Basic Science Foreword,D Jayne,NEPHROLOGY DIALYSIS TRANSPLANTATION 30,,0,2015
Vasculitis: Clinical and Basic Science,D Jayne,Oxford University Press,,0,2015
FP148INFECTIOUS RISK FOLLOWING RITUXIMAB THERAPY IN ANCA ASSOCIATED VASCULITIS,"A Kronbichler, J Kerschbaum, R Jones, R Smith, D Jayne","Nephrology dialysis transplantation 30 (suppl_3), iii116-iii116",,0,2015
Full Review Lupus nephritis management guidelines compared,"S Wilhelmus, IM Bajema, GK Bertsias, DT Boumpas, C Gordon, ...",,,0,2015
Atteinte cardiaque des granulomatoses éosinophiliques avec polyangéite: une fréquence équivalente chez les patients ANCA–et ANCA+?,"CA Durel, J Berthiller, S Caboni, D Jayne, J Ninet, A Hot","La Revue de Médecine Interne 35, A18-A19",,0,2014
Atteinte neurologique périphérique des granulomatoses éosinophiliques avec polyangéite: un facteur pronostique à prendre en compte,"CA Durel, J Berthiller, S Caboni, D Jayne, J Ninet, A Hot","La Revue de Médecine Interne 35, A17-A18",,0,2014
United Kingdom & Ireland Vasculitis Registry-Cross-Sectional Data on the First 1085 Patients.: 1760,"J Sznajd, A Salama, D Jayne, A Chaudhry, M Robson, J Rosa, N Basu, ...",Arthritis & Rheumatology 66,,0,2014
Response to Rituximab in Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register.,"E Sutton, K Watson, D Isenberg, A Rahman, D Jayne, C Gordon, B Parker, ...",Arthritis & Rheumatology 66,,0,2014
"RITUXIMAB-ASSOCIATED HYPOGAMMAGLOBULINAEMIA: INCIDENCE, OUTCOMES AND EFFECT OF DOSE IN PATIENTS WITH MULTI-SYSTEM AUTOIMMUNE DISEASE: 174","R JONES, R SMITH, F ALBERICI, S BURNS, D JAYNE",Nephrology 19,,0,2014
"Rituximab-Associated Hypogammaglobulinaemia: Incidence, Outcomes and Effect of Dose in Patients with Multi-System Autoimmune Disease","DM Roberts, RB Jones, RM Smith, F Alberici, DS Kumaratne, S Burns, ...","Nephrology 19, 64-64",,0,2014
AB0578 Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangitis,"RS Philipson, J Anderson, JC Brown, WW Busse, M Cid, G Gleich, ...","Annals of the Rheumatic Diseases 73 (Suppl 2), 997-997",,0,2014
FRI0455 Renal Function in Anca-Associated Vasculitis is Associated with ENT Involvement,"C Rahmattulla, RAL van Wijngaarden, AE Berden, HA Hauer, ...","Annals of the Rheumatic Diseases 73 (Suppl 2), 552-552",,0,2014
22. Lessons from the European Vasculitis Study Group trials.,D Jayne,"Rheumatology (Oxford, England) 53 (suppl 2), i12-i12",,0,2014
322. Patients with Refractory Systemic Lupus Erythematosus Requiring Biologic Therapy Have Significant Levels of Baseline Co-Morbidities: Results from a National Multi-Centre …,"EJ Sutton, KD Watson, D Isenberg, A Rahman, D Jayne, C Gordon, ...","Rheumatology 53 (suppl_1), i180-i180",,0,2014
"Making treatment personal: measurement of exhaustion to target treatment in autoimmunity, infection, and vaccination","E McKinney, P Lyons, J Lee, D Jayne, KGC Smith","The Lancet 383, S12",,0,2014
Vasculitis and the Kidney,"S Yew, D Jayne","Encyclopedia of Medical Immunology: Autoimmune Diseases, 1241-1254",,0,2014
Microscopic vasculitis associated to Sjögren’s syndrome. About 4 cases,"D Roberts, R Smith, R Jones, F Alberici, H Marco, D Jayne",,,0,2014
L’atteinte ORL des granulomatoses éosinophiliques avec polyangéite: un facteur de bon pronostic sur la survenue de séquelles à long terme?,"CA Durel, J Berthiller, S Caboni, D Jayne, J Ninet, A Hot","La Revue de medecine interne, A31-A32",,0,2014
Efficacy of Oral C5aR Inhibitor CCX168 on Non-Renal Disease Activity in Patients withAntineutrophil Cytoplasmic Antibody-Associated Vasculitis,"DRW Jayne, A Bruchfeld, M Schaier, M Jadoul, M Segelmark, D Selga, ...",American Society of Nephrology,,0,2014
Glucocorticoid Treatment and Damage In The Antineutrophil-Cytoplasm Antibody Associated Vasculitides,"J Robson, H Doll, R Suppiah, O Flossmann, L Harper, P Hoglund, ...",,,0,2013
SP0028 Adults with lupus nephritis,D Jayne,"Annals of the Rheumatic Diseases 71 (Suppl 3), 7-8",,0,2013
"RITAZAREM: AN INTERNATIONAL, OPEN LABEL, RANDOMISED CONTROLLED TRIAL COMPARING RITUXIMAB WITH AZATHIOPRINE AS MAINTENANCE THERAPY IN RELAPSING ANCA ASSOCIATED VASCULITIS","R Smith, M Lewin, R Jones, P Merkel, D Jayne","NEPHROLOGY DIALYSIS TRANSPLANTATION 28, 180-181",,0,2013
Renal vasculitis,"F Alberici, R Smith, R Jones, D Jayne",Nephrology Dialysis Transplantation 28 (suppl_1),,0,2013
LONG TERM FOLLOW UP OF PATIENTS WHO RECEIVED REPEAT DOSE RITUXIMAB AS MAINTENANCE THERAPY FOR ANCA ASSOCIATED VASCULITIS (AAV),"F Alberici, R Smith, R Jones, D Jayne","NEPHROLOGY DIALYSIS TRANSPLANTATION 28, 2-2",,0,2013
Erratum: Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: Data from the European group for blood and marrow transplantation registry (Lupus …,"B Alchi, D Jayne, M Labopin, O Kotova, V Sergeevicheva, T Alexander, ...","Lupus 22 (6), 653",,0,2013
TREATMENT-RELATED DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS,"J Robson, H Doll, S Yew, O Flossmann, R Suppiah, L Harper, P Hoglund, ...",,,0,2013
Oral Abstracts 1,"J Robson, H Doll, S Yew, O Flossmann, R Suppiah, L Harper, P Hoglund, ...",Rheumatology 52 (suppl_1),,0,2013
BHPR: Audit and Clinical Evaluation103. Dental Health in Children and Young Adults with Inflammatory Arthritis: Access to Dental Care,"E Sutton, K Watson, D Isenberg, A Rahman, C Gordon, CS Yee, P Lanyon, ...",Rheumatology 52 (suppl_1),,0,2013
Long-term outcome of severe alveolar hemorrhage in ANCA-associated vasculitis: A retrospective cohort study,"Z Hruskova, A Casian, P Konopasek, B Svobodova, D Frausova, ...","La Presse Médicale 42 (4), 752",,0,2013
Fixed-interval repeat dose rituximab improves abnormalities in the periperhal B cell compartment and reduces relapse rates in ANCA associated vasculitis,"E Wallin, R Smith, R Jones, D Jayne, K Smith","La Presse Médicale 42 (4P2), 772",,0,2013
Cardiovascular outcomes and prognostic predictors in ANCA-associated vasculitis,"C Yuste, A Casian, C Jironda, D Jayne","La Presse Médicale 42 (4P2), 748-749",,0,2013
Quantifying the effect of rituximab on changes in serum immunoglobulin G,"D Roberts, R Smith, R Jones, F Alberici, H Marco, D Jayne","La Presse Médicale 42 (4P2), 766-767",,0,2013
CHARACTERISTICS OF PATIENTS WITH REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS REQUIRING BIOLOGIC THERAPY IN A UK MULTICENTRE COHORT,"EJ Sutton, KD Watson, D Isenberg, A Rahman, C Gordon, CS Yee, ...","RHEUMATOLOGY 52, 130-130",,0,2013
Renal histopathological classification of ANCA associated glomerulonephritis: A validation study of 92 patients,"EDS Amorim, AR Abando, A Casian, D Jayne","La Presse Médicale 42 (4P2), 735-736",,0,2013
Predicting renal relapse with the histopathologic classification of ANCA-associated glomerulonephritis,"A Göçeroğlu, RAFDL Van Wijngaarden, AE Berden, K Westman, ...","La Presse Médicale 42 (4P2), 750-751",,0,2013
ENT involvement is related to better renal function in patients with ANCA-associated vasculitis,"C Rahmattulla, RAFDL Van Wijngaarden, AE Berden, HA Hauer, ...","La Presse Médicale 42 (4P2), 662-663",,0,2013
"A scoring tool for ear, nose and throat disease activity and damage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","J Der Kureghian, P Jani, D Jayne","La Presse Médicale 42 (4P2), 700",,0,2013
Limited otological eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)–a new disease subset,"J Der Kureghian, N Donnelly, P Axon, P Jani, D Jayne","La Presse Médicale 42 (4), 699",,0,2013
"The ear, nose and throat manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)","J Der Kureghian, P Jani, D Jayne","La Presse Médicale 42 (4P2), 699",,0,2013
Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan,"S Furuta, A Chaudhry, Y Hamano, S Fujimoto, H Nagafuchi, S Ozaki, ...","La Presse Médicale 42 (4P2), 733",,0,2013
BHPR: Audit and Clinical Evaluation 103. Dental Health in Children and Young Adults with Inflammatory Arthritis: Access to Dental Care,"P Cornell, A Trehane, P Thompson, F Rahmeh, M Greenwood, TJ Baqai, ...","Rheumatology 52 (suppl_1), i95-i134",,0,2013
STEM CELL FACTOR EXPRESSION IS INCREASED IN THE SKIN OF PATIENTS WITH SYSTEMIC SCLEROSIS AND PROMOTES PROLIFERATION AND MIGRATION OF FIBROBLASTS IN VITRO,"S Karrar, X Shiwen, J Nikotorowicz-Buniak, DJ Abraham, C Denton, ...","RHEUMATOLOGY 52, 135-135",,0,2013
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis: A randomized controlled trial. PEXIVAS,"B Brezina, D Jayne","La Presse Médicale 42 (4), 772",,0,2013
Rituximab and vascular function in granulomatosis with polyangiitis (GPA),"A Casian, K Maki-Petaja, J Cheriyan, A Hubsch, I Wilkinson, D Jayne","La Presse Médicale 42 (4P2), 738-739",,0,2013
Markers for work disability in ANCA-associated vasculitis,"N Basu, A Mcclean, L Harper, M Little, R Luqmani, O Flossmann, D Jayne, ...","La Presse Médicale 42 (4P2), 745-746",,0,2013
Reply: To PMID 22614882.,"M Faurschou, K Westman, N Rasmussen, O Flossmann, P Höglund, ...","Arthritis and rheumatism 65 (3), 844-844",,0,2013
Traitement des syndromes de Churg et Strauss réfractaires par rituximab,"A Hot, MJ Guerry, N Amudala, L Guillevin, PA Merkel, J Ninet, D Jayne","La Revue de medecine interne, A43-A44",,0,2013
3-D printouts of the tracheobronchial tree generated from CT DICOM files as an aid to planning future interventional management in a case of extensive tracheobronchial …,"M Tam, S Laycock, D Jayne, J Babar, B Noble","Journal of Radiology Case Reports 7 (8), 34-43",,0,2013
"Phase 2 clinical trial of CCX168, an orally administered C5aR antagonist, in patients with ANCA-associated renal vasculitis (CLEAR)","A Bruchfeld, M Schaier, L Harper, M Jadoul, M Segelmark, I Szombati, ...",American Society of Nephrology,,0,2013
A Risk Score for Predicting Short-Term Incidence of Death or Relapse in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.: 2564,"C Maldini, M Resche-Rigon, D Jayne, K Westman, A Mahr",Arthritis & Rheumatism 64,,0,2012
Determinants of poor quality of life in ANCA associated vasculitis (AAV).,"N Basu, A McClean, R Luqmani, L Harper, O Flossmann, D Jayne, M Little, ...","Arthritis & Rheumatism 64 (Supplement S10), S653-S653",,0,2012
P16. 06: Longitudinal condition specific fetal growth charts in antiphospholipid syndrome and systemic lupus erythematosus,"A Vitulo, A Daemen, F Hall, D Jayne, T Bourne, D Timmerman, C Lees","Ultrasound in Obstetrics & Gynecology 40 (S1), 231-231",,0,2012
The disease characteristics of ANCA associated vasculitis: 735 patients recruited at diagnosis to six European vasculitis study group trials,"S Yew, D Jayne, P Hoglund, K Westman, R Luqmani, J Robson, A Mahr, ...",Nephrology 17,,0,2012
Airway stenosis in granulomatosis with polyangiitis (Wegener's)-cambridge experience: T197,"M Del Pero, F Riffat, D Jayne, P Sivasothy, P Jani",Clinical Otolaryngology 37,,0,2012
CONTEXTUALISING QUALITY OF LIFE IN ANCA ASSOCIATED VASCULITIS (AAV),"N Basu, A McClean, R Luqmani, L Harper, O Flossmann, D Jayne, M Little, ...",ANNALS OF THE RHEUMATIC DISEASES 71,,0,2012
Auto‐immune cholangiopathy in a juvenile patient with systemic lupus erythematosus,"G Noble‐Jamieson, D Jayne, E Hook","Acta Paediatrica 101 (6), e262-e264",,0,2012
THE DEMOGRAPHY OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY GROUP TRIALS,"S Yew, D Jayne, K Westman, P Hoglund, O Flossman, A Mahr, R Luqmani, ...",,,0,2012
PLASMA EXCHANGE INDUCES VITAMIN D DEFICIENCY,"TF Hiemstra, A Casian, P Boraks, D Jayne, I Schoenmakers","NEPHROLOGY DIALYSIS TRANSPLANTATION 27, 150-151",,0,2012
Primary and secondary glomerulonephritis I,"N Miyazaki, J Matsumoto, F Alberici, A Palmisano, F Maritati, E Oliva, ...","Nephrology Dialysis Transplantation 27 (suppl_2), ii182-ii196",,0,2012
BILAG BIOLOGICS PROSPECTIVE COHORT: THE USE OF NOVEL BIOLOGICAL THERAPIES IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS IN THE UNITED KINGDOM,"EJ Sutton, KD Watson, C Gordon, CS Yee, P Lanyon, D Jayne, ...","RHEUMATOLOGY 51, 179-180",,0,2012
Mineral and bone disease-CKD 1-5,"ZY Loh, CW Yap, V Anantharaman, P How, M Hirata, K Aizawa, K Yogo, ...","Nephrology Dialysis Transplantation 27 (suppl_2), ii146-ii158",,0,2012
Essentials in rheumatology: disease management I34. Metabolic bone diseases,"J Compston, O Fitzgerald, A Rahman, M Roberts, C Oddis, B Abrahamsen, ...","Rheumatology 51 (suppl_3), iii7-iii13",,0,2012
Mycophenolate or Azathioprine Maintenance in Lupus Nephritis REPLY,"MA Dooley, D Jayne, N Solomons","NEW ENGLAND JOURNAL OF MEDICINE 366 (6), 573-573",,0,2012
How can we predict the risk of relapse in antineutrophil cytoplasmic antibody-associated vasculitis? Comment on the article by Walsh et al Reply,"M Walsh, K Westman, D Jayne","Arthritis and Rheumatism 64 (9), 3058-3058",,0,2012
"New etiopathogenic knowledge, or politics? Comment on the article by Falk et al","R Falk, C Jennette, W Gross, L Guillevin, G Hoffman, D Jayne, ...",Arthritis & Rheumatism 63 (9),,0,2011
Détermination des sous-classes phénotypiques des vascularites associées aux ANCA: une étude par la méthode d’analyse «cluster»,"A Mahr, S Katsahian, H Varet, L Guillevin, C Pagnoux, K Westman, ...","La revue de médecine interne 32 (S1), 80",,0,2011
Clinical nephrology/Glomerulonephritis,"E Plaisier, B Terrier, A Karras, A Lacraz, I Marie, JE Kahn, G Le Guenno, ...","Nephrology Dialysis Transplantation Plus 4 (suppl_2), 4. s2. 15",,0,2011
The prognostic value of BVAS and VDI in ANCA-AAV,"R Suppiah, R Batra, J Robson, P Hoglund, D Jayne, K Westman, ...",,,0,2011
Cluster analysis and clinical phenotypes of anti-ANCA-AAV,"A Mahr, S Katsahian, H Varet, L Guillevin, C Hagen, P Höglund, P Merkel, ...","Clinical and Experimental Immunology 164, 80-81",,0,2011
Predicting cardiovascular events in patients with newly diagnosed ANCA-AAV,"R Suppiah, A Judge, R Batra, K Javaid, D Jayne, P Seo, R Luqmani",Clinical and Experimental Immunology 164,,0,2011
An unusual neurological manifestation of WG,"R Smith, D Jayne","Clinical and Experimental Immunology 164, 110-111",,0,2011
Proposal for a randomized controlled trial comparing RTX to standard immunosuppression as maintenance therapy in ANCA-AAV,"R Smith, R Jones, K Smith, D Jayne",Clinical and Experimental Immunology 164,,0,2011
Airway stenosis in WG: the Cambridge experience,"M Del Pero, D Jayne, P Sivasothy, P Jani",Clinical and Experimental Immunology 164,,0,2011
Peripheral neuropathy in ANCA-AAV,"R Suppiah, R Hadden, R Batra, M Collins, L Guillevin, D Jayne, R Luqami","Clinical and Experimental Immunology 164, 120-121",,0,2011
Validation of a disease activity scoring system for the assessment of ENT complaints in WG,"M Del Pero, A Chaundhry, P Jani, D Jayne, N Rasmussen",Clinical and Experimental Immunology 164,,0,2011
Rituximab trials,D Jayne,Clinical and Experimental Immunology 164,,0,2011
THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS,"R Suppiah, R Batra, J Robson, N Arden, O Flossmann, L Harper, ...",,,0,2011
Vasculitis: 265. Cryoglobulinemic Vasculitis Secondary to Hepatitis C Infection: Is Prediction of Disease Severity Feasible?,"RA Ionescu, IC Daha, M Sisiroi, C Tanasescu, B Dasgupta, C Crowson, ...","Rheumatology 50 (suppl_3), iii145-iii148",,0,2011
Preventing Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis—Reply,"TF Hiemstra, M Walsh, DRW Jayne","JAMA 305 (10), 996-997",,0,2011
Annals of Rheumatic Diseases 2011 Mar; 70 (3): 414-422,"S van Assen, N Agmon-Levin, O Elkayam, R Cervera, MF Doran, ...",Influenza vaccination in primary and secondary immunodeficiencies 70 (3 …,,0,2011
Mykofenolát mofetil udržuje remisi lupusové nefritidy lépe než azathioprin,"MA Dooley, D Jayne, EM Ginzler","Novinky v nefrologii, 91",,0,2011
IL-1 blockade for Schnitzler's syndrome,"RM Smith, HJ Lachmann, DRW Jayne","WILEY-BLACKWELL 164, 111-111",,0,2011
Antineutrophil cytoplasmic antibodies (ANCA) stimulate neutrophil microparticle release causing endothelial activation and increased thrombin generation.,"Y Hong, D Eleftheriou, AAK Hussain, FE Price-Kuehne, CO Savage, ...",Journal of the American Society of Nephrology,,0,2011
ORIGINAL INVESTIGATIONS-Pathogenesis and Treatment of Kidney Disease-Plasma Exchange for Renal Vasculitis and Idiopathic Rapidly Progressive Glomerulonephritis: A Meta-analysis,"M Walsh, F Catapano, W Szpirt, K Thorlund, A Bruchfeld, L Guillevin, ...","American Journal of Kidney Diseases 57 (4), 566",,0,2011
"MULTIPLE CRANIAL NEUROPATHIES, A RARE COMPLICATION OF SYSTEMIC SCLEROSIS","A Oomatia, A Young, FC Hall, DR Jayne, AJ Coles, N Shenker, MS Zandi, ...","CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 29 (1), 191-191",,0,2011
Rituximab or Cyclophosphamide in ANCA-Associated Renal Vasculitis,"R Jones, D Jayne","The New England Journal of Medicine 363 (21), 2073-2074",,0,2010
RITUXIMAB VERSUS CYCLOPHOSPHAMIDE IN ANCA ASSOCIATED RENAL VASCULITIS,"C Peh, R Jones, M Walsh, D Jayne",Nephrology 15,,0,2010
Comparison of interferon-{gamma} release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study,"N Bosu, R Watts, I Bajema, B Basland, T Bley, M Boers, P Brogan, ...",Annals of the Rheumatic Diseases,,0,2010
MEASUREMENT OF DAMAGE IN SYSTEMIC VASCULITIS: A COMPARISON OF THE VASCULITIS DAMAGE INDEX (VDI) WITH THE COMBINED DAMAGE ASSESSMENT INDEX (CDA),"R Suppiah, O Flossman, C Mukhtyar, F Alberici, B Baslund, D Brown, ...",,,0,2010
Vasculitis [232–238] Primary Systemic Vasculitis: A 10 Year True to Life Study from a North London District General Hospital,"K Chakravarty, I Saeed, J Sajna, AP Kiprianos, LD Church, M Little, ...","Rheumatology 49 (suppl_1), i122-i124",,0,2010
An update on autologous stem cell transplantation in severe systemic lupus erythematosus and in early diabetes type 1,"D Farge, R Cervera, D Jayne, A Voskuyl, JM van Laar, A Doria, M Mosca, ...","BONE MARROW TRANSPLANTATION 45, S7-S8",,0,2010
Prospective study of TNFalpha blockade with adalimumab in ANCA-associated systemic vasculites with renal involvement. Nephrol Dial Transplant 2010 Oct 25 (10): 3307-14. Epub …,"S Laurino, A Chaudhry, A Booth, G Conte, D Jayne",,,0,2010
STEM CELL TRANSPLANTATION IN SLE,D Jayne,Bone Marrow Transplantation 45 (1),,0,2010
Consensus statement Mycophenolic acid therapies for autoimmune disease: A consensus statement,"D Jayne, L Harper, S Harper, A Salama, M Scholtz","British Journal of Renal Medicine 15 (2), 25",,0,2010
B cell depletion with rituximab for refractory ENT Wegener's granulomatosis,"M Pero, A Chaudhry, R Jones, P Sivasothy, P Jani, D Jayne",Clinical Otolaryngology 34,,0,2009
Nasal involvement in Wegener's granulomatosis-a detailed assessment of 144 patients: PR43,"M Pero, A Chaudhry, P Jani, D Jayne",Clinical Otolaryngology 34,,0,2009
Prospective assessment of long-term damage to the ENT system in Wegener's granulomatosis,"M Pero, M Walsh, P Jani, D Jayne",Clinical Otolaryngology 34,,0,2009
A history of ENT granulomatous disease and vasculitis: PH01,"M Pero, P Jani, D Jayne",Clinical Otolaryngology 34,,0,2009
Health-related quality of life in patients with ANCA-associated vasculitis: a pooled analysis of four randomized clinical trials,"M Walsh, C Muktyar, A Mahr, K Herlyn, R Luqmani, D Jayne",Apmis 117,,0,2009
One year renal function predicted by intraepithelial T cells in patients with ANCA-associated vasculitis treated with rituximab,"A Berden, R Jones, D Erasmus, LH Noël, F Ferrario, R Waldherr, J Bruijn, ...","Apmis 117, 73-74",,0,2009
Pulse vs daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: a randomized controlled trial,"L Harper, K De Groot, D Jayne, L Suarez, G Gregorini, W Gross, ...",Apmis 117,,0,2009
ENT involvement is related to better renal function in patients with ANCA-associated vasculitis,"RL van Wijngaarden, H Hauer, O FloBmann, D Jayne, G Gaskin, ...",Apmis 117,,0,2009
Prospective analysis of predictive otolaryngology signs and symptoms of disease activity in Wegener's granulomatosis,"M Del Pero, A Chaudhry, P Jani, D Jayne",Apmis 117,,0,2009
A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe,"T Ito-Ihara, E Muso, S Kobayashi, K Uno, N Tamura, Y Yamanishi, ...",Apmis 117,,0,2009
Capture ELISA for PR3 ANCA reflects disease activity in NORAM patients,"A Salmela, N Rasmussen, D Jayne, A Ekstrand",Apmis 117,,0,2009
"Ear, nose and throat involvement in Wegener's granulomatosis: a detailed assessment of 144 patients","M Del Pero, A Chaudhry, P Jani, D Jayne",Apmis 117,,0,2009
Prospective study of TNF-α blockade with adalimumab in ANCA-associated systemic vasculitis with renal involvement: A20,"S Laurino, D Jayne, A Chaudhry, A Booth",Apmis 117,,0,2009
Health-related quality of life in ANCA-associated vasculitis treated with a rituximab-based regimen vs cyclophosphamide: A8,"M Walsh, R Jones, D Jayne",Apmis 117,,0,2009
Risk epitopes of MPO-ANCA in patients with MPA in Japan,"K Suzuki, K Tomizawa, T Nagao, S Kobayashi, E Muso, W Yumura, ...",Apmis 117,,0,2009
Early mortality in systemic vasculitis: relative contribution of therapy-associated adverse events and active vasculitis,"M Little, P Nightingale, T Hauser, K de Groot, C Savage, D Jayne, ...",Apmis 117,,0,2009
Autologous stem cell transplantation for severe systemic lupus Erythematosus: the EBMT approved ASTIL TRIALD,"D Farge, JM van Laar, D Jayne, A Voskuyl, R Cervera, A Doria, F Hiepe, ...","Bone Marrow Transplantation 43 (S1), S36-S36",,0,2009
Predictors of long-term (>= 5 year) renal survival in 535 patients with ANCA-associated vasculitis,"A Berden, O Flossmann, K Westman, P Höglund, EC Hagen, S le Cessie, ...","APMIS1988-01-01+ 01: 00 117, 150-150",,0,2009
EULAR Recommendations for monitoring systemic,"L Carmona, A Tincani, RF van Vollenhoven, MM Ward, VP Werth, ...",,,0,2009
Late breaking clinical trials,"B Fellström, AG Jardine, H Holdaas, R Schmieder, M Gottlow, E Johnsson, ...","NDT Plus 2 (suppl_2), ii1514",,0,2009
Outcomes of a UK cohort of AAV patients treated with TNF blockade,"A Kai, L Espinel-Costoso, S Trivedi, A Casal, M Morgan, J Levy, MA Little, ...","Apmis 117, 74-74",,0,2009
Glomerulonephritis-1,"E Pillebout, C Alberti, L Guillevin, E Thervet, CESAR Study Group, ...","NDT Plus 2 (suppl_2), ii1029",,0,2009
Optimizing the Birmingham vasculitis activity scale to predict end-stage renal disease and death in ANCA-associated vasculitis,"M Walsh, O Flossman, A Berden, K Westman, B Manns, D Jayne","APMIS1988-01-01+ 01: 00 117, 140-140",,0,2009
Assessment of damage in vasculitis: Expert ratings of damage,"P Seo, DR Jayne, RA Luqmani, PA Merkel",,,0,2008
Validation of a new version of the Birmingbam vasculitis activity score,"C Mukhtyar, D Brown, R Lee, C Hall, D Jayne, P Lanyon, D Carruthers, ...",,,0,2008
"Diseases of Glomeruli, Microvasculature, and Tubulointerstitium","AS Appel, GB Appel, R De Caterina, C Zoccali, D Jayne, SJ Chadban, ...",Therapy in Nephrology and Hypertension E-Book: A Companion to Brenner …,,0,2008
B cell cytokines as novel biomarkers to predict relapse and guide rituximab re-treatment in systemic lupus erythematosus (SLE) and ANCA associated vasculitis (AAV),"AJ Shah, RD Jones, D Jayne, KG Smith, MR Clatworthy","RHEUMATOLOGY 47, II93-II93",,0,2008
Renal Vasculitis in the Elderly,D Jayne,"The Aging Kidney in Health and Disease, 373-384",,0,2008
Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis,"DR Jayne, G Gaskin, N Rasmussen","ACP JOURNAL CLUB 148 (1), 11",,0,2008
Plasmapheresis in Renal Diseases,D Jayne,Therapy in Nephrology and Hypertension E-Book: A Companion to Brenner …,,0,2008
Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis.,"HA Hauer, R Wolterbeek, DR Jayne, G Gaskin, N Rasmussen, LH Noël, ...","Journal of the American Society of Nephrology: JASN 18 (7), 2189-2197",,0,2007
Littérature commentée,"DR Jayne, G Gaskin, N Rasmussen, D Abramowicz, F Ferrario, ...","La revue de médecine interne 28, 893-896",,0,2007
Rituximab and mycophenolate mofetil; novel remission induction agents in ANCA associated vasculitis,"RB Jones, DRW Jayne","CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 25 (1), S113-S113",,0,2007
SPECIAL SECTIONS-METHODS AND SCIENCE IN NEPHROLOGY-Surrogate end points in clinical trials: The case of anti-neutrophil cytoplasm antibody-associated vasculitis,"M Walsh, M Tonelli, D Jayne, B Manns","Journal of Nephrology 20 (2), 119-129",,0,2007
"Epidemiology of renal ANCA-associated vasculitis in the UK and Japan. Volume 25, Issue 1, Pages S95-S95, Suppl. 44","RA Watts, DGI Scott, S Fujimoto, S Kobayashi, K Suzuki, S Shigeto, ...","CLINICAL & EXPER RHEUMATOLOGY, VIA SANTA MARIA 31, 56126 PISA, ITALY",,0,2007
ABAVAS: A trial of CTLA4Ig in ANCA vasculitis,"A Salama, C Pusey, D Jayne, K Mosley","CLIN EXP RHEUMATOL 25 (1), S114-S114",,0,2007
Translation of renal histology into clinical severity of ANCA-associated vasculitis,"RAF de Lind van Wijngaarden, HA Hauer, DRW Jayne, G Gaskin, ...","CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 25 (1), S94-S94",,0,2007
C. Hypertension and Systemic Disease,"M Walsh, M James, D Jayne","Clin J Am Soc Nephrol 2 (5), 968-975",,0,2007
EULAR recommendations for conducting clinical studies and/or clinical trials in ANCA-associated vasculitis,"R Luqmani, O Flossmann, DRW Jayne, B Hellmich, E Taskforce",CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 25 (1),,0,2007
Prospective clinical trial of Gusperimus (deoxyspergualin) in refractory Wegener's granulomatosis,"O Flossmann, B Baslund, A Bruchfeld, JW Cohen Tervaert, P Heinzel, ...",CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 25 (1),,0,2007
Randomised trial of enteric-coated mycophenolate versus mycophenolate mofetil in multi-system autoimmune disease,"R Jones, K Smith, D Jayne","NEPHROLOGY DIALYSIS TRANSPLANTATION 22, 93-93",,0,2007
Incidence of ANCA-associated vasculitis in Japan: A preliminary report from a Japan-UK collaboration study.,"S Kobayashi, T Ito-Ihara, K Suzuki, S Fujimoto, RA Watts, DGI Scott, ...","CLINICAL & EXPER RHEUMATOLOGY, VIA SANTA MARIA 31, 56126 PISA, ITALY",,0,2007
A systematic review and meta-analysis of relapses in AAV: What is the effect of low-dose corticosteroids?,"M Walsh, P Merkel, A Mahr, D Jayne","NEPHROLOGY DIALYSIS TRANSPLANTATION 22, 282-282",,0,2007
EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: Focus on anti-neutrophil...,"O Flossmann, DGI Scott, J WITTER, H YAZICI","Annals of the rheumatic diseases 66 (5), 605-617",,0,2007
Clinical and histological determinants of long-term outcome in ANCA-associated glomerulonephritis,"WRAF de Lind, HA Hauer, O Flossmann, DRW Jayne, KW Westman, ...","CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 25 (1), S115-S115",,0,2007
"Doc. MUDr. Ondřej Viklický, CSc.","ECF Wilson, DRW Jayne, E Delow","V ý b ě rzes V ě to V é literaturysklinick ý mikoment á ř i, 39",,0,2007
Prospective clinical trial of Gusperimus (deoxyspergualin) in refractory or relapsing Wegener's granulomatosis: An interim report,"O Flossmann, D Jayne","NEPHROLOGY DIALYSIS TRANSPLANTATION 21, 557-557",,0,2006
Clinical Science Articles-Epidemiology and Outcomes-Clinical and Histologic Determinants of Renal Outcome in ANCA-Associated Vasculitis: A Prospective Analysis of 100 Patients …,"RAF Lind van Wijngaarden, HA Hauer, R Wolterbeek, DRW Jayne, ...","Journal of the American Society of Nephrology 17 (8), 2264-2274",,0,2006
"Contents Vol. 102, 2006","SD Kim, BS Cho, M Koukoulaki, DRW Jayne, H Pereyra, E Freixas, ...","Nephron Clinical Practice 102 (3-4), c145-c145",,0,2006
"Author Index Vol. 102, 2006","SD Kim, BS Cho, M Koukoulaki, DRW Jayne, H Pereyra, E Freixas, ...","Nephron Clinical Practice 102 (3-4), c143-c143",,0,2006
"Subject Index Vol. 102, 2006","SD Kim, BS Cho, M Koukoulaki, DRW Jayne, H Pereyra, E Freixas, ...","Nephron Clinical Practice 102 (3-4), c144-c144",,0,2006
Ongoing european research initiatives in systemic vasculitides: The EUVAS program,"RA Luqmani, D Jayne",,,0,2005
Vasculitis and lupus nephritis,D JAYNE,"The Year in Renal Medicine 1, 165",,0,2005
303. INFLIXIMAB IN A DIFFICULT CASE OF TAKAYASU'S ARTERITIS,"LE Coates, AK Bhalla, J Ravindran, D Jayne, CL Hall",Rheumatology 44,,0,2005
307. LIVEDOID VASCULOPATHY-A CASE REPORT,"AR Joshi, AV Kuttikat, D Jayne, K Chakavarty",Rheumatology 44,,0,2005
OP26. THERAPY IN VASCULITIS,D Jayne,"Rheumatology 44 (suppl_3), iii11-a-iii11-a",,0,2005
VASCULITIS AS A MODEL TO EXPLORE THE LINK BETWEEN CARDIOVASCULAR DISEASE AND INFLAMMATION,"I Wilkinson, C McEniery, S Wallace, I Mackenzie, D Jayne, J Cockcroft, ...",Clinical and Experimental Pharmacology and Physiology 31,,0,2004
INFLAMMATION AND ARTERIAL STIFFNESS IN SYSTEMIC VASCUUTIS: A MODEL OF VASCULAR INFLAMMATIONP 134,"AD Booth, S Wallace, CM McEniery, Y Yasmin, J Brown, DRW Jayne, ...","Journal of Hypertension 22, S44",,0,2004
INFLIXIMAB IMPROVES ENDOTHELIAL DYSFUNCTION IN SYSTEMIC VASCULITIS: A MODEL OF VASCULAR INFLAMMATIONP 135,"AD Booth, DRW Jayne, RK Kharbanda, CM McEniery, IS MacKenzie, ...","Journal of Hypertension 22, S44",,0,2004
Clinical Nephrology-Prospective Study of TNFa Blockade with Infliximab in Anti-Neutrophil Cytoplasmic Antibody-Associated Systemic Vasculitis,"A Booth, L Harper, T Hammad, P Bacon, M Griffith, J Levy, C Savage, ...","Journal of the American Society of Nephrology 15 (3), 717-721",,0,2004
Inflammation and arterial stiffness in systemic vasculitis: A model of vascular inflammation.,"AD Booth, S Wallace, CM McEniery, Yasmin, DRW Jayne, IB Wilkinson","JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 14, 522A-522A",,0,2003
Treatment and outcome of patients with primary focal segmental glomerulosclerosis in 5 UK renal units.,"C Stirling, P Mathieson, M Boulton-Jones, J Feehally, D Jayne, J Adu","JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 14, 526A-526A",,0,2003
6.3. Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation,"A Booth, S Wallace, Y Yasmin, C McEniery, D Jayne, I Wilkinson",Journal of Human Hypertension 17 (10),,0,2003
Author Index for Abstracts,"D Jayne, V Tesař, JWC Tervaert, JH Stone, JSF Sanders, CA Stegeman, ...","Kidney and Blood Pressure Research 26 (4), 300-302",,0,2003
"11th International Vasculitis and ANCA Workshop-October 2-5, 2003, Prague, Czech Republic","V Tesar, D Jayne","KIDNEY & BLOOD PRESSURE RESEARCH 26 (4), 214-214",,0,2003
IV TREATMENT AND OUTCOMES-KEYNOTE PRESENTATION-Conventional Treatment and Outcome of Wegener's Granulomatosis and Microscopic Polyangiitis,"C Pusey, F Woude, DRW Jayne","Cleveland Clinic Journal of Medicine 69 (2), 110-115",,0,2002
Renal vasculitis,D Jayne,"HORIZONS IN MEDICINE 13, 137-148",,0,2002
IV TREATMENT AND OUTCOMES-PLENARY SESSION ABSTRACT-25-070 CAMPATH 1-H (ANTI-CD52) FOR REFRACTORY VASCULITIS: RETROSPECTIVE CAMBRIDGE EXPERIENCE 1989-1999,"C Pusey, F Woude, DRW Jayne","Cleveland Clinic Journal of Medicine 69 (2), 129-129",,0,2002
"IV TREATMENT AND OUTCOMES-PLENARY SESSION ABSTRACT-24-012 RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE VERSUS METHOTREXATE FOR INDUCTION OF REMISSION IN"" NON-RENAL"" ANCA-ASSOCIATED …","C Pusey, F Woude, K Groot, N Rasmussen, JW Cohen Tervaert, ...","Cleveland Clinic Journal of Medicine 69 (2), 116-116",,0,2002
Immune Vasculitis,"S Gopaluni, D Jayne","eLS, 1-8",,0,2001
Birmingham Vasculitis Activity Score (BVAS) for use in European multi-centre clinical trials,"RA Luqmani, PA Bacon, N Rasmussen, D Jayne",Rheumatology 40,,0,2001
The use of Tacrolimus in ocular inflammatory disease.,"W Ayliffe, S Watson, D Jayne","INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 42 (4), S464-S464",,0,2001
S3. Rituximab for ANCA-associated vasculitides: The French experience,D Jayne,"Arthritis Rheum 44, 2836-40",,0,2001
Placebo-controlled trial of intravenous immunoglobulin in ANCA-associated systemic vasculitis.,"D Jayne, H Chapel, J Adu, D O'Donoghue, S Misbah, D Scott, ...",KIDNEY INTERNATIONAL 55 (6),,0,1999
European vasculitis trials: a progress report.,"G Gaskin, D Jayne","KIDNEY INTERNATIONAL 55 (6), 2591-2591",,0,1999
CASE REPORTS AND SMALL CASE SERIES-Branch Retinal Arteriolar Occlusion Associated With Familial Factor V Leiden Polymorphism and Positive Rheumatoid Factor,"S Dhar-Munshi, WH Ayliffe, D Jayne","Archives of Ophthalmology-Chicago 117 (7), 971-973",,0,1999
European randomized trials in ANCA-associated systemic vasculitis: A progress report (Jan 97).,"DRW Jayne, G Gaskin","KIDNEY INTERNATIONAL 52 (4), 1130-1130",,0,1997
Diagnostic value of standardized assays for ANCA in systemic vasculitis,"DRW Jayne, G Gaskin, CD Pusey, CM Lockwood","KIDNEY INTERNATIONAL 52 (1), 272-272",,0,1997
1 Drop attacks in the elderly revisited AB Dey and RA Kenny 5 Vertical transmission of human immunodeficiency virus J. Morrison and NJ Alp 13 Malignant hyperthermia …,"RB Abraham, A Cahana, RM Krivosic-Horber, A Perel, MJ Allen, BJ Myer, ...",,,0,1997
Kortikosteroid-Einsparung bei Riesenzellarteriitis?,"GS Hoffman, GS Kerr, RY Leavitt, CW Hallahan, RS Lebovics, WD Travis, ...","Mayo Clin Proc 72, 737-747",,0,1997
Systemic disorders with rheumatic manifestations: Rheumatologie manifestations of gastrointestinal disorders B11,"V Hamuryudan, Y Ozyazgan, H Yazici, H Hasegawa, M Nakano, ...","children 129, 604-607",,0,1996
EUROPEAN TRIALS IN SYSTEMIC VASCULITIS,"D JAYNE, G GASKIN, CM LOCKWOOD, N RASMUSSEN","JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 6 (3), 923-923",,0,1995
Novel IgA antinueotrophil cytoplasmic antibodies (ANCA) against phospholipid targets in inflammatory bowel disease,"M Hamilton, P Ardiles, P Chapman, D Jayne, R Pounder, AJ Wakefield, ...","Gastroenterology 108 (4), A831",,0,1995
Regulation and Significance of Anti-neutrophil Cytoplasm Autoantibodies in Systemic Vasculitis,DRW Jayne,University of Cambridge,,0,1995
24 Treatment of systemic vasculitis,"DRW Jayne, CM Lockwood","Advanced renal medicine, 279",,0,1992
"Pathogenetic Mechanisms in Vasculitis, III: IgG Subclass Distribution of Anti-Myeloperoxidase Antibodies in Systemic Vasculitis","VLM Esnault, DRW Jayne, CE Rawlinson, AP Weetman, CM Lockwood","Clinical Science 80 (s24), 33P-34P",,0,1991
The renal lesion of the more common small-vessel vasculitides—Wegener's granulomatosis and microscopic polyarteritis—is most often a focal necrotizing crescentic …,"DRW JAYNE, CM LOCKWOOD","Immunology of Renal Diseases 16, 255",,0,1991
Autoimmunity in Systemic Vasculitis,"DRW Jayne, CM Lockwood","Immunology of Renal Disease, 255-269",,0,1991
Intravenous immunoglobulin or plasma exchange alone can induce remission in systemic vasculitis,"DRW Jayne, CM Lockwood","Apmis 98 (S19), 64-64",,0,1990
TREATMENT OF SYSTEMIC VASCULITIS WITH INTRAVENOUS IMMUNOGLOBULIN OR PLASMA-EXCHANGE ALONE,"DRW JAYNE, PW MATHIESON, CM LOCKWOOD","CLINICAL RESEARCH 38 (2), A268-A268",,0,1990
ANTI-IDIOTYPES TO ANTI-NEUTROPHIL CYTOPLASM ANTIBODIES (ANCA) ARE PRESENT IN POOLED HUMAN-IMMUNOGLOBULIN AND CONVALESCENT SERA,"D JAYNE, F ROSSI, M KAZATCHKINE, CM LOCKWOOD","KIDNEY INTERNATIONAL 37 (1), 441-441",,0,1990
SEQUENTIAL ANTI-NEUTROPHIL CYTOPLASM ANTIBODY-TITERS IN THE MANAGEMENT OF SYSTEMIC VASCULITIS,"A HEATON, D JAYNE, A BROWNLEE, DB EVANS, CM LOCKWOOD","KIDNEY INTERNATIONAL 37 (1), 440-440",,0,1990
"Renal Association Meeting, 12-13 May 1988, Belfast, Ulster","SP Haemorrhage, DRW Jayne, SJ Jones, CM Lockwood","Nephrol Dial Transplant 3, 837-845",,0,1988
Severe Pulmonary Haemorrhage and Systemic Vasculitis in Association with Circulating IGM Anti-Neutrophil Antibody,"DRW Jayne, SJ Jones, CM Lockwood, A Severn, S Shaunak, J Murphy","Clinical Science 73 (s17), 27P-27P",,0,1987
autoantibodies to neutrophil cytoplasm enzymes16,"G Frampton, DRW Jayne, GJ Perry","interferon 77, 1428-35",,0,1986
Outcome of participants with nephrotic syndrome in combined clinical trials of lupus nephritis.,"MD Cascino, TR Katsumoto, P Brakeman, P Brunetta, D Jayne, M Dall'Era, ...",,,0,0
Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Sch o,"F Maritati, R Fenoglio, E Pillebout, G Emmi, ML Urban, R Rocco, ...",,,0,0
Department of Medicine,"A Lever, U Desselberger, L Dolken, S Nejentsev, S Peacock, J Sinclair, ...",,,0,0
Abstract Reviewers,"D Abraham, Y Ahmad, N Amft, M Anderson, J Andrews, E Baildem, ...",,,0,0
QUIZ PAGE,"YJ Su, CH Lee, SC Huang, FR Chuang, DE Weiner, LA Stevens, M Walsh, ...",,,0,0
Je léčba lupusové nefritidy mykofenolátem ve srovnání s pulsním cyklofosfamidem efektivní z hlediska kvality života a nákladů na léčbu?,"ECF Wilson, DRW Jayne, E Delow",,,0,0
1035 journal club nephrology digest,"Y Hirakawa, M Nangaku, JV Bonventre, F Massa, A Schedl, A Kronbichler, ...",,,0,0
A Novel Presentation of Multiple Cranial Neuropathies in Systemic Sclerosis,"A Oomatia, AMH Young, S Rae, DRW Jayne, AJ Coles, FC Hall, ...",,,0,0
Translational Immunology in Kidney Disease,"HJ Anders, D Jayne, B Rovin",,,0,0
i12 Sunday 24 November 2013,D Jayne,"Rheumatology 53 (1), 17",,0,0
1.8 Other Clinical Research,"A Casian, M Walsh, A Berden, D Jayne",,,0,0
TO018 MIGRATION OF HUMAN UMBILICAL CORD BLOOD STEM CELLS TO TUBULAR EPITHELIUM AFTER XENOTRANSPLANTATION INTO SCID MICE KIDNEYS,"R Jones, S Burns, K Smith, D Jayne",,,0,0
tém měsíci kt. Studie,"ECF Wilson, DRW Jayne, E Delow",,,0,0
"ISN Nexus Symposium 2016 Highlights: Translational Immunology in Kidney Disease, Berlin, Germany, April 14 ‚Äì17, 2016","HJ Anders, D Jayne, B Rovin",,,0,0
